Disease
MONDO:0000001A disease is a disposition to undergo pathological processes that exists in an organism because of one or more disorders in that organism.
Also known as: condition, disease, disease or disorder, disease or disorder, non-neoplastic, diseases, diseases and disorders, disorder, disorders
90897 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Showing the 400 most recently updated of 13198 trials in this tab.
-
New HIV vaccine strategy aims to prime and boost immune defenses
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a two-part HIV vaccine in healthy adults who do not have HIV. The vaccine uses a DNA 'prime' followed by a protein 'boost' to train the immune system against multiple HIV strains. Researchers are checking if the vaccine is safe and whether it triggers a strong im…
Phase: PHASE2 • Sponsor: Worcester HIV Vaccine • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
Could a Liver-Stage malaria vaccine shield mothers and babies?
⭐️ VACCINE ⭐️ Not yet recruitingThis phase 2 trial tests a new malaria vaccine (PfSPZ-LARC2) designed to stop the malaria parasite in the liver before it can cause illness. The study involves 300 healthy women of childbearing age in Mali who plan to become pregnant. Participants receive three doses of the vacci…
Phase: PHASE2 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
Experimental drug aims to reverse liver damage in rare triple condition
Disease control Not yet recruitingThis study tests a drug called foscenvivint in people with liver cirrhosis caused by HIV and hepatitis C co-infection who also have hemophilia. Participants receive the drug once a week for 24 weeks. Researchers will check if the drug improves liver function and is safe to use.
Phase: PHASE2 • Sponsor: Kiminori Kimura, MD • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New MS drug trial for kids: could ocrelizumab help?
Disease control Not yet recruitingThis study tests a drug called ocrelizumab in children and teens aged 10 to 17 with relapsing-remitting multiple sclerosis (MS). The goal is to see how the drug moves through the body, if it is safe, and how it affects the immune system. Participants will receive the drug as a sh…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill aims to ease Parkinson's motor symptoms when added to standard therapy
Disease control Not yet recruitingThis phase 2 trial tests whether ENERGI-F705 tablets, taken twice daily alongside standard Parkinson's medications, can improve motor function and safety in people aged 40–75 with idiopathic Parkinson's disease. Participants are randomly assigned to receive a high dose, low dose,…
Phase: PHASE2 • Sponsor: Energenesis Biomedical Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Surgical fix for failed lung valve treatment shows promise in early trial
Disease control Not yet recruitingThis trial investigates a surgical procedure to divide the fissure between lung lobes in people with COPD and emphysema who did not improve after endobronchial valve treatment. The goal is to see if the surgery is safe and feasible, potentially leading to better lung collapse and…
Phase: NA • Sponsor: Rocco Bilancia • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Clot-Removal procedure may offer hope for severe brain stem strokes
Disease control Not yet recruitingThis trial investigates whether a procedure to remove a blood clot from the basilar artery—a major vessel at the back of the brain—can improve recovery in people with severe stroke. Participants are adults aged 18 to 80 who have a large area of brain damage and can be treated wit…
Phase: NA • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Eye injection shows promise in preventing repeat retinal detachment
Disease control Not yet recruitingThis early-stage study tests whether an injection of the drug topotecan into the eye can safely prevent retinal detachment from coming back in people with a condition called proliferative vitreoretinopathy (PVR). About 50 adults having retinal detachment surgery will either recei…
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Blood filters aim to reverse organ failure in septic shock
Disease control Not yet recruitingThis study tests whether special blood purification devices can help people with septic shock, a life-threatening condition where infection causes organ failure. The trial includes adults aged 18 to 80 with severe septic shock. Depending on their level of endotoxins, patients rec…
Phase: NA • Sponsor: Moscow Multidisciplinary Clinical Center "Kommunarka" • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Radioactive drug targets Hard-to-Treat thyroid cancer
Disease control Not yet recruitingThis study tests a radioactive drug called 177Lu-DOTA-EB-TATE in 18 adults with a rare thyroid cancer (Hurthle cell) that has spread and not responded to standard radioactive iodine treatment. The drug is designed to seek out and attach to cancer cells. Participants will receive …
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Eye injection aims to clear fluid in chronic vision disorder
Disease control Not yet recruitingThis trial investigates whether faricimab, an eye injection, can help people with chronic central serous chorioretinopathy (CSCR), a condition where fluid builds up under the retina and can cause vision loss. The study includes 50 adults with persistent fluid for at least three m…
Phase: PHASE2 • Sponsor: Singapore National Eye Centre • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn solid tumors
Disease control Not yet recruitingThis trial tests a new approach for people with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own myeloid cells, a type of immune cell, which are genetically modified in a lab to produce a cancer-fighting protein called IL…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy aims to free Beta-Thalassemia patients from lifelong transfusions
Disease control Not yet recruitingThis study tests a single-dose gene therapy for people with transfusion-dependent beta-thalassemia, a blood disorder that requires regular red blood cell transfusions. The therapy uses a patient's own stem cells, modified with a virus to produce healthy hemoglobin, and then infus…
Phase: PHASE2 • Sponsor: Fondazione Telethon • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain stimulation and sling workouts: a promising combo for stroke recovery?
Disease control Not yet recruitingThis study tests whether combining a gentle electrical brain stimulation (called FNS) with sling-based exercises can help people who have paralysis on one side after a stroke. The trial will enroll 54 adults aged 18-70 who had a stroke within the last 6 months. Participants will …
Phase: NA • Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat myeloma
Disease control Not yet recruitingThis study tests a new treatment called AZD4045, which uses specially engineered immune cells (CAR-T cells) to target and kill multiple myeloma cells. The therapy is given alone or combined with other drugs (daratumumab and aldesleukin) in adults whose myeloma has returned or sto…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Drug combo aims to shrink Hard-to-Treat anal cancer
Disease control Not yet recruitingThis phase 2 trial tests whether the combination of pembrolizumab (an immunotherapy) and lenvatinib (a targeted therapy) can shrink tumors in people with advanced anal squamous cell cancer that cannot be removed by surgery or has spread to other organs. Participants must have alr…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for rare immune disorders: upadacitinib trial launches
Disease control Not yet recruitingThis study tests the drug upadacitinib (Rinvoq) in 30 people with rare genetic disorders that overactivate the JAK-STAT immune pathway. The trial has four phases over 12 months, including an open-label phase to find the best dose and a randomized withdrawal phase to compare the d…
Phase: PHASE1, PHASE2 • Sponsor: Lisa Satter • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a gentle electric field heal the heart? new study tests Pulsed-Field ablation for persistent AF
Disease control Not yet recruitingThis study looks at whether pulsed-field ablation (PFA), a non-thermal technique that uses electric pulses to target faulty heart tissue, can reverse structural changes in the heart caused by persistent atrial fibrillation (AF). Researchers will enroll 30 people with persistent A…
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug DS1025a takes on advanced solid tumors in first human trial
Disease control Not yet recruitingThis trial is testing a new drug called DS1025a in people with advanced solid tumors that have spread, cannot be removed by surgery, or have stopped responding to other treatments. The main goals are to check the drug's safety, how the body processes it, and whether it shows any …
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for young adults with CML: asciminib under Real-World scrutiny
Disease control Not yet recruitingThis study looks at how well the drug asciminib works and how safe it is for young adults with chronic myeloid leukemia (CML) in the Gulf region. Researchers will collect information from medical records of about 80 people aged 18 and older who have taken asciminib. The main goal…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Quarter-Sized implant could free type 1 diabetes patients from daily insulin
Disease control Not yet recruitingThis early-stage trial tests a small, soft implant that holds donor insulin-making cells (islets) and protects them from the immune system. The goal is to see if the device is safe and keeps the cells alive and working in adults with type 1 diabetes. Some participants are also on…
Phase: PHASE1 • Sponsor: Encellin • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New biologic aims to tackle stubborn high triglycerides
Disease control Not yet recruitingThis phase 3 trial tests an investigational injectable drug called DR10624 in adults with severe hypertriglyceridemia (very high blood fats) that remains high despite standard treatment. Participants continue their usual omega-3 therapy and receive weekly injections of DR10624 or…
Phase: PHASE3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill targets rosacea inflammation at its source
Disease control Not yet recruitingThis study tests an oral medication called remibrutinib for adults with moderate-to-severe papulopustular rosacea, a skin condition causing red bumps and pustules on the face. The drug works by blocking a protein involved in inflammation. Researchers will measure whether it reduc…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental drug aims to halt rare neurological decline
Disease control Not yet recruitingThis Phase 3 trial tests whether vatiquinone can slow the progression of Friedreich's ataxia, a rare genetic disorder that damages the nervous system and impairs movement. About 120 adults with moderate symptoms will take the drug for 24 months. Researchers will measure changes i…
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Blood pressure drug may curb alcohol cravings in heavy drinkers
Disease control Not yet recruitingThis study tests whether nimodipine, a blood pressure medication, can reduce alcohol consumption and craving in adults with Alcohol Use Disorder who are heavy drinkers. Participants receive nimodipine or a placebo over 18 hours, then take part in a controlled drinking session whe…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New trial aims to stop stomach bleeding before it starts
Disease control Not yet recruitingThis study tests whether treating enlarged stomach veins (gastric varices) early with a procedure called retrograde transvenous obliteration (RTO) can prevent dangerous bleeding. 68 adults with cirrhosis and gastric varices will be randomly assigned to either RTO or standard care…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase trial tests a new therapy for people with advanced small cell lung cancer or similar neuroendocrine cancers that have not responded to prior treatment. The approach involves collecting a patient's own immune cells, modifying them in a lab to recognize a protein c…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New Once-Daily pill aims to tame ADHD symptoms in korean youth
Disease control Not yet recruitingThis phase 3 trial tests whether viloxazine extended-release capsules, taken once daily, can safely reduce ADHD symptoms in Korean children and adolescents aged 6 to 17. Participants receive either the drug or a placebo for 8 weeks, with doses adjusted based on response. The stud…
Phase: PHASE3 • Sponsor: Alvogen Korea • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New coil treatment could replace surgery for bleeding hemorrhoids
Disease control Not yet recruitingThe BRIGHT study will follow 250 adults with grade II-III hemorrhoids who are treated with a procedure called hemorrhoid artery embolization (HAE). This technique uses tiny metal coils to block blood flow to the hemorrhoids, aiming to stop bleeding without major surgery. Research…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New daily pill aims to tame stubborn seizures in tuberous sclerosis
Disease control Not yet recruitingThis study tests an oral drug, AV078, in people aged 12 and older with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard medications. Participants are randomly assigned to receive AV078 or a placebo for 12 weeks. The goal is to see if AV078 safely red…
Phase: PHASE2 • Sponsor: Aeovian Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Cream-and-Steroid combo aims to recolor vitiligo patches
Disease control Not yet recruitingThis study tests whether a cream containing ruxolitinib (Opzelura) combined with corticosteroid injections or pills can improve facial vitiligo. It includes people aged 12 and older with active, non-segmental vitiligo affecting the face. Participants use the cream twice daily and…
Sponsor: ShanShan Li • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug duo aims to outsmart EGFR-mutant lung cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding an experimental drug called izalontamab brengitecan to the standard targeted therapy osimertinib works better than osimertinib alone or with chemotherapy for people with advanced EGFR-mutant non-small cell lung cancer who have not had prior…
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans may end guesswork in treating stubborn depression
Disease control Not yet recruitingThis study tests whether brain imaging and clinical data can help select the best treatment for people with depression that hasn't improved with standard therapies. Participants receive either repetitive transcranial magnetic stimulation (rTMS) or ketamine, and researchers check …
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Nurse-Led mobile clinics aim to tame high blood pressure in liberia
Disease control Not yet recruitingThis study tests whether a nurse-led, community-based program can help lower blood pressure in adults aged 25 and older with uncontrolled hypertension in Monrovia, Liberia. Trained community health nurses provide medication and lifestyle counseling at mobile clinics in high-traff…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drugs aim to slow muscle decline in duchenne muscular dystrophy
Disease control Not yet recruitingThis study tests two experimental drugs, ENTR-601-44 and ENTR-601-45, in people with Duchenne muscular dystrophy (DMD) who have already taken part in earlier studies. The goal is to see if long-term use is safe and tolerable, and whether it can help maintain muscle function. Part…
Phase: PHASE2 • Sponsor: Entrada Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
One-Time gene injection aims to rescue sight in rare childhood blindness
Disease control Not yet recruitingThis study tests a gene therapy called OPGx-RDH12 for people with Leber Congenital Amaurosis (LCA) caused by mutations in the RDH12 gene, a rare condition that leads to severe vision loss from a young age. The treatment is given as a single injection under the retina in the worse…
Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Personalized stem cell transplant aims to beat inherited blood cancers
Disease control Not yet recruitingThis study tests whether adjusting chemotherapy doses for each patient can improve outcomes after a stem cell transplant for blood cancers caused by a RUNX1 gene mutation. Up to 98 people aged 4 to 70 with these cancers will receive a transplant from a half-matched donor. The goa…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Two-Drug sequence aims to clear CLL cells and let patients stop treatment
Disease control Not yet recruitingThis phase 2 trial tests a treatment plan for people with newly diagnosed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Participants first take zanubrutinib alone for 12 cycles, then add sonrotoclax for another 12 cycles. The goal is to see if this seque…
Phase: PHASE2 • Sponsor: Yi Shuhua • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Triple-Drug cocktail aims to tackle Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a combination of three drugs—tislelizumab, bevacizumab, and capecitabine—in people with advanced solid tumors. The trial focuses on two challenging groups: those whose cancers have stopped responding to immunotherapy and those with tumors that have spread to the …
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Neck surgery may help clear brain waste in Alzheimer's patients
Disease control Not yet recruitingThis trial investigates whether a surgical procedure that connects lymph vessels in the neck to veins, combined with the standard drug donepezil, can slow cognitive decline in people with moderate Alzheimer's disease. The surgery aims to improve drainage of waste from the brain, …
Phase: NA • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental drug aims to improve breathing in lung sarcoidosis
Disease control Not yet recruitingThis study tests an investigational drug called XTMAB-16 in people with pulmonary sarcoidosis, a condition that causes inflammation and scarring in the lungs. The trial aims to see if the drug can improve lung function (measured by forced vital capacity) and quality of life. Part…
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs, olomorasib and pembrolizumab, as a first treatment for people with advanced non-small cell lung cancer that has a KRAS G12C mutation and a PD-L1 score between 1% and 49%. The main goal is to see how long patients live without t…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could an immune drug ease schizophrenia symptoms?
Disease control Not yet recruitingThis phase 2 trial tests whether ublituximab, an immune-modulating drug, can reduce symptoms in people with treatment-resistant schizophrenia. Participants receive the drug by IV infusion, and researchers measure changes in symptom scores over time. The goal is to see if targetin…
Phase: PHASE2 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a school-based trauma program keep incarcerated teens from turning to drugs?
Disease control Not yet recruitingThis pilot study tests a behavioral program called CBITS-RTM, adapted for teens in juvenile detention. The program combines group and individual therapy to address post-traumatic stress and includes a module on racial trauma. Researchers want to see if it reduces PTSD symptoms an…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo aims to tame HPV throat cancer with fewer side effects
Disease control Not yet recruitingThis early-phase trial tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation to the neck can safely and effectively treat early-stage HPV-positive throat cancer before surgery. About 35 participants will take the drug daily for 10 days and receive …
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a simple phosphate IV ease severe pancreatitis?
Disease control Not yet recruitingThis study investigates whether giving phosphate through an IV can reduce the severity of acute pancreatitis in adults. Researchers want to know if low phosphate levels make the disease worse and if replenishing it helps. Participants receive either standard care or IV phosphate …
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Exercise may boost immunotherapy in kidney cancer
Disease control Not yet recruitingThis study explores whether adding high-intensity interval training (HIIT) to standard immunotherapy (nivolumab plus ipilimumab) helps patients with advanced kidney cancer. Thirty participants are randomly assigned to either a supervised exercise program or usual care. Researcher…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a diabetes drug boost chemo for tough cancers?
Disease control Not yet recruitingThis early-phase trial will test whether adding semaglutide (a GLP-1 drug used for diabetes and weight loss) to standard chemotherapy is safe and tolerable for people with metastatic pancreatic, colorectal, or liver cancer. About 30 participants will receive weekly semaglutide in…
Phase: EARLY_PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New vaccine combo aims to halt prostate cancer growth without surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug aimed at stopping lung rejection in transplant patients
Disease control Not yet recruitingThis early-stage trial tests a drug called fostamatinib in 30 adults who have developed donor-specific antibodies after a lung transplant. These antibodies can attack the new lung and raise the risk of death. Participants take fostamatinib or a placebo for 8 weeks, along with the…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Laser vs. scalpel: which heals anal fistula faster?
Disease control Not yet recruitingThis study compares two ways to treat uncomplicated perianal fistula: conventional open surgery (fistulectomy) and a newer laser ablation technique. About 72 adults with a single, simple fistula tract will be randomly assigned to one of the two procedures. Researchers will track …
Phase: NA • Sponsor: PNS Hafeez - Naval Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New catheter aims to dissolve dangerous lung clots more precisely
Disease control Not yet recruitingThis pilot study tests a new catheter device designed to deliver clot-dissolving medication directly to blood clots in the lungs of adults with intermediate-risk pulmonary embolism. The goal is to see if the device can be used safely and as intended. All 20 participants will rece…
Phase: NA • Sponsor: Flow Medical Solutions, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Laser and 'Skin Booster' injection may reverse sun damage and prevent cancer
Disease control Not yet recruitingThis study tests whether combining a fractional laser with a biostimulator (poly-L-lactic acid) can repair sun-damaged skin better than either treatment alone. The goal is to improve skin health and potentially lower the risk of skin cancer. Researchers will use AI-assisted imagi…
Phase: NA • Sponsor: Bispebjerg Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental cell therapy takes on tough leukemia
Disease control Not yet recruitingThis early-phase trial tests a new treatment called TSLPR-CART for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified in a lab to target a protein called TSLPR found on …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy could free Wilson's patients from daily pills
Disease control Not yet recruitingThis early-stage trial tests a single-dose gene therapy called LY-M003 in 18 adults with Wilson's disease, a genetic condition that causes copper buildup. The goal is to see if it's safe and can reduce or eliminate the need for standard daily medications. Participants receive one…
Phase: PHASE1, PHASE2 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New study tracks Real-World safety of odevixibat in rare liver disease
Disease control Not yet recruitingThis study will follow 30 people with Alagille syndrome who are taking odevixibat in their daily lives. The goal is to see how safe the drug is over the long term by tracking any side effects. It is not testing if the drug works, but rather monitoring its real-world safety.
Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New registry tracks Dupilumab's Real-World impact on COPD
Disease control Not yet recruitingThis registry will follow 350 COPD patients starting dupilumab (Dupixent) to see how well it works and how safe it is in real life. Researchers will track flare-ups, lung function, and quality of life over 24 months, comparing them to similar patients not on the drug. The goal is…
Sponsor: Sanofi • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans reveal how Weight-Loss drugs rewire appetite in teens vs adults
Disease control Not yet recruitingThis study investigates how semaglutide (the drug in Ozempic and Wegovy) changes brain activity related to appetite and eating in people with obesity. Researchers will compare teenagers (ages 12–18) and adults (ages 30–45) using brain scans and meal tests to see if the drug affec…
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to shrink liver tumors before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs (ateganosine and cadonilimab) before surgery can safely shrink liver tumors in people with resectable hepatocellular carcinoma. About 60 participants will receive either one or both drugs before their operation. The main goal is to see if…
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could same-day activation of cochlear implants speed up hearing recovery?
Disease control Not yet recruitingThis study compares activating a cochlear implant on the day of surgery versus the usual two-week wait. About 100 adults receiving a cochlear implant will be randomly assigned to one of the two groups. Researchers will track how quickly the implant settings stabilize, hearing imp…
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Dissolvable scaffolds could save legs from amputation in major new trial
Disease control Not yet recruitingThis Europe-wide study will follow 400 people with severe leg artery disease (chronic limb-threatening ischemia) to see if a new dissolvable, drug-coated scaffold can keep leg arteries open better than standard treatments. The scaffold releases medication to prevent re-blockage a…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug shows promise for lung scarring in Long-Term safety trial
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called admilparant in people with pulmonary fibrosis (lung scarring). About 2,277 adults who finished earlier studies will take the drug and be monitored for side effects. The goal is to see if the drug is safe to use over time, …
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Video Game-Style breathing exercises could help kids with cerebral palsy
Disease control Not yet recruitingThis study tests a fun, game-based training program that teaches children with cerebral palsy how to breathe better and improve their posture. The program includes exercises like blowing out candles and floating boats, along with visual and audio cues. Researchers want to see if …
Phase: NA • Sponsor: Yeditepe University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Earpiece zaps nerves to shrink Radiation-Damaged brain swelling
Disease control Not yet recruitingThis trial tests whether a gentle electrical earpiece, worn twice daily for two weeks, can reduce brain swelling caused by radiation necrosis. The device stimulates a nerve in the ear to calm inflammation. Forty people with brain tumors who need a laser procedure will be randomly…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a tailored diet make a MASH drug work better?
Disease control Not yet recruitingThis study tests whether adding a Mediterranean-style meal delivery program to resmetirom therapy improves liver health more than resmetirom alone. It involves 120 adults with non-cirrhotic MASH who are starting resmetirom. Participants either receive the drug plus 10 medically t…
Phase: PHASE4 • Sponsor: City University of New York • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail aims to tackle Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis study tests a new biologic drug called HCB101 in combination with other cancer drugs (zolbetuximab and chemotherapy) for people with advanced gastric or gastro-esophageal cancer. The goal is to find a safe dose and see if the combination can shrink tumors. About 40 adults wi…
Phase: PHASE1, PHASE2 • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered immune cells target deadly brain tumors in children
Disease control Not yet recruitingThis study tests a new treatment called BCB-276 for children and young adults with diffuse intrinsic pontine glioma (DIPG), a rare and aggressive brain tumor. BCB-276 is made from a patient's own immune cells, which are modified in a lab to recognize and attack the cancer. The tr…
Phase: PHASE2 • Sponsor: BrainChild Bio, Inc • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New triple therapy aims to slow advanced lung cancer
Disease control Not yet recruitingThis study tests a new combination of three drugs (nivolumab, ipilimumab, and nogapendekin alfa inbakicept) for people with stage IV or recurrent non-small cell lung cancer. The goal is to see if this treatment helps keep the cancer from growing longer than standard two-drug ther…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Smart nursing cuts kidney damage risk in liver cancer patients
Disease control Not yet recruitingThis study tests whether a personalized nursing program can prevent acute kidney injury (AKI) in people with liver cancer who undergo interventional therapy. Researchers first use a prediction model to classify patients into low, moderate, or high risk for AKI. Then, they provide…
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Two-Drug cocktail aims to boost chemo against tough lung cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding two experimental drugs, imzokitug and pumitamig, to standard chemotherapy helps people with advanced non-small cell lung cancer (NSCLC) who have not had prior treatment. About 160 participants will receive either the three-drug combination …
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Triple-Drug attack aims to stop liver cancer recurrence after surgery
Disease control Not yet recruitingThis phase II trial investigates whether adding SHR-8068 to a two-drug regimen (adebrelimab and apatinib) can improve outcomes for people with liver cancer that can be surgically removed but has a moderate-to-high risk of coming back. Participants receive the drug combination bef…
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Bicycle therapies offer continued hope for advanced tumors
Disease control Not yet recruitingThis trial provides continued access to three experimental Bicycle therapies—zelenectide pevedotin, nuzefatide pevedotin, and BT7480—for people with advanced solid tumors who are already benefiting from them in another study. Participants continue their same treatment while resea…
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New study tests orbital atherectomy to save limbs in patients with severe leg artery disease
Disease control Not yet recruitingThis study will follow 250 people with chronic limb-threatening ischemia (CLTI) across Europe to see how well orbital atherectomy works in real life. The procedure uses a tiny spinning tool to gently remove hard calcium from leg arteries, making it easier for balloons or stents t…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a supplement and drug combo help treat obesity?
Disease control Not yet recruitingThis Phase 2 trial tests whether combining the supplement alpha-lipoic acid with the drug mirabegron can improve how the body processes sugar in people with obesity. Sixty adults aged 18 to 65 with a BMI between 30 and 45 will take the combination or a placebo for 4 weeks. The st…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for ITP patients: switching drugs after failed treatment
Disease control Not yet recruitingThis study looks at 112 people with immune thrombocytopenia (ITP) whose platelet counts didn't improve after standard treatment with rhTPO. After a two-week break, they will either get a higher dose of rhTPO or switch to a different drug called eltrombopag. The goal is to see whi…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Which sedative best protects the brain after injury? trial pits three common drugs Head-to-Head
Disease control Not yet recruitingThis trial compares three sedatives—propofol, midazolam, and dexmedetomidine—for controlling pressure inside the skull after urgent brain surgery for moderate-to-severe traumatic brain injury. Adults who have had surgery within 24 hours of injury will receive one of the three dru…
Phase: NA • Sponsor: Aswan University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pastille could change head and neck cancer treatment
Disease control Not yet recruitingThis large Phase 3 trial is testing a new drug called APG-157, given as a pastille that dissolves in the mouth, for people with advanced head and neck cancer. The study will see if adding APG-157 before and after standard treatments (surgery or chemoradiation) helps keep the canc…
Phase: PHASE3 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Faster, better baby tooth root canals? trial pits two rotary file systems Head-to-Head
Disease control Not yet recruitingThis trial compares two types of rotary files designed for children's primary molars: Fanta AF Baby and EndoArt Pedo Blue. The goal is to see which system prepares root canals faster and with better filling quality during a pulpectomy (removing infected pulp). Thirty children age…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for tough myeloma: early trial of BP2202 begins
Disease control Not yet recruitingThis early-stage trial is testing a new drug called BP2202 in 24 people with multiple myeloma that has come back or no longer responds to standard treatments. The main goal is to see if BP2202 is safe and to find the best dose. Researchers will also watch for any signs that the d…
Phase: PHASE1 • Sponsor: BrightPath Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Targeted combo aims at tough lymphoma subtype
Disease control Not yet recruitingThis phase 2 trial tests whether adding the targeted drug orelabrutinib to standard chemotherapy improves outcomes for people with a specific genetic subtype of diffuse large B-cell lymphoma (MCD subtype). Participants receive the drug combination during initial treatment, follow…
Phase: PHASE2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug KK2223 enters early human testing for Tough-to-Treat T-Cell lymphoma
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called KK2223 in 72 adults with T-cell lymphoma (a type of blood cancer) that has returned or not responded to prior treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processe…
Phase: PHASE1 • Sponsor: Kyowa Kirin, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New ventilation strategy aims to reduce lung damage in severe pneumonia
Disease control Not yet recruitingThis study tests a new way of using a breathing machine (ventilator) called time-controlled adaptive ventilation (TCAV) in people with severe lung injury from pneumonia. The goal is to see if TCAV reduces fluid buildup in the lungs compared to standard ventilation. The trial invo…
Phase: NA • Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Light therapy vs chemical peels: which zaps precancerous spots better?
Disease control Not yet recruitingThis study compares two treatments for actinic keratoses—rough, scaly spots that can turn into skin cancer—on the arms. One treatment uses a light-sensitizing gel followed by blue light (photodynamic therapy), while the other uses a two-step chemical peel. About 60 adults with sp…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a monthly shot replace weekly diabetes injections?
Disease control Not yet recruitingThis study tests whether people with type 2 diabetes can switch from a weekly injection of dulaglutide to a once-monthly shot called PG-102. The trial involves 60 adults whose blood sugar is well-controlled on dulaglutide. Researchers will compare blood sugar levels and safety ov…
Phase: PHASE2 • Sponsor: ProGen. Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Balloon catheter may shield the brain from debris during artery stenting
Disease control Not yet recruitingThis trial tests whether using a balloon guide catheter along with a filter can better protect the brain during carotid artery stenting. People with narrowed neck arteries (carotid stenosis) who need stenting are randomly assigned to get either the balloon-plus-filter combo or a …
Phase: NA • Sponsor: Hebei General Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to outperform current therapy in Hard-to-Treat breast cancer
Disease control Not yet recruitingThis study compares a new experimental drug, BL-M07D1, to an approved therapy (DS-8201) in people with a common form of advanced breast cancer (HR-positive, HER2-low). The goal is to see if the new drug can delay cancer growth or improve survival. About 120 women aged 18 to 75 wi…
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New stem cell filtering method could make transplants safer for kids
Disease control Not yet recruitingThis early-phase study tests a new way to do stem cell transplants for children and young adults with blood diseases. Doctors will take stem cells from a family member or closely matched unrelated donor, filter out certain immune cells using a special machine, and then give them …
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug duo takes on recurrent brain cancer
Disease control Not yet recruitingThis study tests whether an investigational drug called HF1K16, when combined with the approved drug bevacizumab, can help people with recurrent or progressive glioma—a type of brain tumor. The trial enrolls about 30 adults whose tumors have returned or worsened after prior treat…
Phase: PHASE2 • Sponsor: HighField Biopharmaceuticals Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Video games may help fight childhood obesity and diabetes
Disease control Not yet recruitingThis study looks at whether playing active video games can help children and young adults (ages 5-21) with obesity and type 2 diabetes lose weight and lower their blood sugar levels. Participants will play active video games at home, and researchers will track changes in weight a…
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a diabetes injection curb cannabis cravings? small trial aims to find out
Disease control Not yet recruitingThis 12-week study tests whether a weekly injection of tirzepatide, a drug used for diabetes, combined with motivational therapy can help adults with moderate to severe cannabis use disorder. Fifteen participants will receive escalating doses of tirzepatide along with counseling.…
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Alpelisib's Long-Term safety tracked in PIK3CA patients
Disease control Not yet recruitingThis study provides continued access to alpelisib for people who are already benefiting from it in a previous Novartis trial. It focuses on tracking long-term safety, including any side effects, in participants with PIK3CA-related overgrowth spectrum or certain breast cancers. Pa…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill hopes to calm Crohn's Flare-Ups
Disease control Not yet recruitingThis early-stage study tests a new drug called zasocitinib (TAK-279) in 20 adults with active Crohn's disease who have not responded to other treatments. The main goal is to see if the drug is safe and how it affects inflammation in the gut. Participants will take the drug for 12…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Two-Drug combo aims to shrink vulvar tumors before surgery
Disease control Not yet recruitingThis trial tests whether combining an immune-boosting cream (imiquimod) with a low dose of an immunotherapy drug (nivolumab) can shrink vulvar squamous cell carcinoma tumors before surgery. About 50 women with resectable, early-to-moderate stage vulvar cancer will receive the dru…
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Gentle hand massage may heal bedsores faster, pilot study suggests
Disease control Not yet recruitingThis pilot study tests whether adding manual lymphatic drainage (a gentle massage technique) to standard wound care can help heal pressure injuries (bedsores) in patients hospitalized in intensive care. The trial randomly assigns 60 adults with a pressure injury on the sacrum (ta…
Phase: NA • Sponsor: Rukiye Kokkiz • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Smart breathing machines at home could cut hospital visits for COPD patients
Disease control Not yet recruitingThis study looks at whether adding a home telemonitoring system to standard nighttime breathing support (non-invasive ventilation) can help people with severe COPD and high carbon dioxide levels. About 92 participants will be split into two groups: one using standard home ventila…
Sponsor: Air Liquide Healthcare Spain • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a Cholesterol-Lowering injection help lung cancer patients stay on a key treatment?
Disease control Not yet recruitingThis study tests whether recakimab, an injectable drug that lowers cholesterol, can safely reduce high cholesterol caused by the lung cancer medication lorlatinib. The trial enrolls about 29 adults with advanced ALK-positive non-small cell lung cancer who developed high cholester…
Phase: PHASE4 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Combination therapy aims to wipe out High-Risk prostate cancer before surgery
Disease control Not yet recruitingThis trial investigates whether combining a targeted radioactive drug (177Lu-PSMA-617) with a hormone therapy (darolutamide) before surgery can improve outcomes for men with high-risk localized prostate cancer. Participants receive two doses of the radioactive drug and daily horm…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a website and a buddy help tame diabetes? large trial puts it to the test.
Disease control Not yet recruitingThis study tests whether helping people with diabetes find local resources (like food or housing help) and pairing them with a peer supporter can improve blood sugar and blood pressure. About 694 adults with diabetes who have trouble controlling their condition will be randomly a…
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple-Drug cocktail targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis phase I trial is testing whether combining three drugs—pacritinib, venetoclax, and azacitidine—is safe and tolerable for people with accelerated or blast phase myeloproliferative neoplasms, aggressive blood cancers. The study enrolls about 20 adults whose disease has progres…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Sound waves and herbs take on 'Non-Killing Cancer' of keloid scars
Disease control Not yet recruitingThis study tests a new approach for treating keloids—thick, raised scars that can be painful and itchy. The treatment combines wide-band ultrasound with a traditional Chinese medicine preparation applied to the skin. The goal is to soften scar tissue, reduce symptoms, and prevent…
Phase: PHASE1, PHASE2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Combination therapy aims to outsmart tough lymphoma
Disease control Not yet recruitingThis phase 2 trial tests whether adding the drug nemtabrutinib to a CAR T-cell therapy called brexu-cel can help people with mantle cell lymphoma that has come back or not responded to treatment. Nemtabrutinib blocks a protein that helps cancer cells grow, while brexu-cel uses a …
Phase: PHASE2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New program aims to keep ex-inmates on track for recovery
Disease control Not yet recruitingThis study tests a program called MISSION-CJ that helps people leaving jail who have both mental health and substance use disorders. The program connects them with peer support and community services to stay in treatment and avoid relapse. Researchers will track how well particip…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Vacuum-Assisted sheath aims to clear kidney stones faster
Disease control Not yet recruitingThis trial tests whether a vacuum-assisted ureteral access sheath (ClearPetra) removes kidney stones more completely than a standard rigid sheath (Navigator) during flexible ureteroscopy. About 156 adults with stones 1-3 cm will be randomly assigned to one sheath. The main goal i…
Phase: NA • Sponsor: Hospitales Universitarios Virgen del Rocío • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail targets rare liver cancer in 29-Patient trial
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs (tremelimumab and durvalumab) plus chemotherapy (gemcitabine and cisplatin) in people with a rare, advanced liver cancer called combined hepatocellular-cholangiocarcinoma that cannot be removed by surgery or has spread. Ab…
Phase: PHASE2 • Sponsor: Mehmet Akce • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a pill replace CPAP for sleep apnea? large study tests three treatments Head-to-Head
Disease control Not yet recruitingThis study compares three treatments for obstructive sleep apnea: positive airway pressure (CPAP), a dental device that moves the jaw forward, and a combination of two medications (atomoxetine and oxybutynin). About 2,400 adults with sleep apnea will be randomly assigned to one o…
Phase: PHASE4 • Sponsor: Sairam Parthasarathy • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to slow kidney damage in rare alport syndrome
Disease control Not yet recruitingThis study tests a drug called exaluren in 24 people aged 12 and older with Alport syndrome caused by specific genetic errors. The drug is given as a daily shot for 32 weeks. Half the group starts exaluren right away, while the other half gets a placebo first and then switches to…
Phase: PHASE2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a cream make laser treatment for birthmarks more effective?
Disease control Not yet recruitingThis study tests whether a rapamycin cream, applied after laser treatment, can improve the appearance of port wine stain birthmarks in children aged 10 and under. Thirty participants will receive laser therapy plus either a low or high dose of the cream or a placebo cream for 12 …
Phase: PHASE2 • Sponsor: AFT Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New dialysis filter aims to cut inflammation and protect hearts in kidney patients
Disease control Not yet recruitingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can reduce inflammation and improve heart function better than the standard filter in people with end-stage kidney disease. Thirty adults on maintenance hemodialysis will use each filter for three …
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called SI-B036, a bispecific antibody designed to fight advanced gastrointestinal and other solid tumors. The study involves about 16 adults with tumors that have spread or cannot be removed. Researchers aim to find a safe dose and see if t…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Immunotherapy combo may outperform chemo in rare lymphoma
Disease control Not yet recruitingThis Phase 3 trial tests whether an immunotherapy-based regimen (sintilimab, pegaspargase, and anlotinib) works better than standard chemotherapy before a stem cell transplant in people with newly diagnosed, advanced extranodal NK/T-cell lymphoma. Participants are randomly assign…
Phase: PHASE3 • Sponsor: Rong Tao • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take on childhood brain cancer in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment for children and young adults with aggressive brain tumors called high-grade glioma and DIPG. The therapy uses the patient's own immune cells, modified in a lab to better recognize and attack tumor cells. The main goals are to see if t…
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Short burst of radiation before Immuno-Chemo may boost esophageal cancer response
Disease control Not yet recruitingThis study tests whether a short course of radiation followed by the immunotherapy drug tislelizumab plus chemotherapy can improve outcomes for people with a type of esophageal cancer that can be surgically removed. About 50 participants will receive either a low or high dose of …
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail aims to stop triple negative breast cancer from returning
Disease control Not yet recruitingThis Phase 3 trial tests whether a combination of two drugs, trastuzumab rezetecan and adebrelimab, can prevent breast cancer from returning in people with triple negative breast cancer who still have cancer cells after initial chemotherapy and surgery. The study compares this ne…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Inhaled drug could offer new hope for lung scarring disease
Disease control Not yet recruitingThis phase 2 trial tests whether an inhaled form of nintedanib (MNKD-201) is safe and effective for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring. About 210 adults with IPF will receive either a low or high dose of the inhaled drug or a plac…
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Personalized vaccine takes aim at recurrent brain tumors
Disease control Not yet recruitingThis trial tests a personalized vaccine called YS247 for people with recurrent glioblastoma, an aggressive brain cancer. The vaccine is made from each patient's own immune cells and designed to target unique markers on their tumor. The study aims to see if the vaccine is safe and…
Phase: NA • Sponsor: Huanhu Hospital Affiliated to Tianjin Medical University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for Alzheimer's? phase 3 trial of brain-fueling compound begins
Disease control Not yet recruitingThis study tests whether a daily dose of tricaprilin, a type of fat that may provide energy to brain cells, can improve memory, thinking, and daily function in people with mild-to-moderate Alzheimer's disease. About 535 participants will receive either tricaprilin or a placebo fo…
Phase: PHASE3 • Sponsor: Cerecin • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a common ulcer drug prevent deadly bleeding after variceal treatment?
Disease control Not yet recruitingThis trial tests whether applying sucralfate—a medication that forms a protective barrier over wounds—directly onto esophageal ulcers after variceal banding can speed healing and reduce rebleeding. The study includes adults with cirrhosis who have bleeding esophageal varices. Par…
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could an asthma drug help fight lung cancer? early trial investigates
Disease control Not yet recruitingThis pilot study tests whether an inhaled drug called cromolyn sodium, already used for asthma, is safe and feasible for people with locally advanced lung cancer. The drug works by calming mast cells, which may play a role in tumor growth and treatment resistance. About 5 to 10 p…
Phase: PHASE1 • Sponsor: Carcinex Inc • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Drug duo aims to tackle high blood pressure in obesity
Disease control Not yet recruitingThis study tests whether combining two medications, empagliflozin and finerenone, can lower blood pressure in adults with obesity and stage 1 hypertension. Participants take the drugs or a placebo daily for 12 weeks. The trial also measures effects on kidney function, inflammatio…
Phase: NA • Sponsor: Heart Health Research Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat T-Cell cancers
Disease control Not yet recruitingThis study tests a new treatment called nano CD5-CAR T cells for people with relapsed or refractory T-cell acute lymphoblastic leukemia or T-cell lymphoma. The therapy uses a patient's own immune cells, modified in a lab to recognize and attack cancer cells that carry the CD5 pro…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Mobile coaching may help dialysis patients shed excess fluid
Disease control Not yet recruitingThis trial tests a self-management program that uses education, WhatsApp reminders, and a diary to help hemodialysis patients control weight gain between sessions. The program aims to improve fluid adherence and stabilize blood pressure. Participants are adults on maintenance hem…
Phase: NA • Sponsor: National Taipei University of Nursing and Health Sciences • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Heart pump may help High-Risk patients get Life-Saving artery treatment
Disease control Not yet recruitingThis study tests whether using a temporary heart pump (CorVad) during a procedure to open blocked arteries (PCI) can improve outcomes for people with complex coronary artery disease and a very weak heart (ejection fraction below 35%). Half of the 452 participants will receive the…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo aims to boost surgery success in colon cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether giving two drugs—Zanzalintinib and Retifanlimab—before surgery can help patients with early-stage colon cancer. The study enrolls adults aged 18 to 80 with a type of colon cancer called pMMR that can be removed surgically. Participants receiv…
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Double immune attack: new cell combo targets tough childhood cancers
Disease control Not yet recruitingThis early-phase study tests a new combination of two different immune cells—NK cells and CAR-T cells—for children and young adults with neuroblastoma or osteosarcoma that has returned or not responded to standard treatments. The NK cells are designed to help the CAR-T cells work…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Herbal mix and cancer drug join forces to fight fluid in lungs
Disease control Not yet recruitingThis study tests whether adding a Chinese herbal formula (Xuanyin Ning) to a standard cancer drug (bevacizumab) can better control malignant pleural effusion—fluid buildup in the chest caused by advanced lung cancer. About 308 participants will receive either the herbal formula o…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple knee sleeve slow arthritis and ease pain?
Disease control Not yet recruitingThis study tests whether wearing a knee sleeve daily for five years can slow the progression of knee arthritis and reduce pain in adults aged 50 to 64 who have had knee pain for at least three months. Participants are randomly assigned to either wear a knee sleeve every day or no…
Phase: NA • Sponsor: Margaret L Gourlay, MD, MPH • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Heart valve study seeks best blood thinner to prevent clots and bleeding
Disease control Not yet recruitingThis study tests two blood-thinning strategies in people with severe aortic regurgitation who have had a new heart valve placed without open surgery. Participants receive either daily aspirin for a year or warfarin for six months followed by aspirin. The goal is to see which appr…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for bile duct cancer: experimental drug faces final test
Disease control Not yet recruitingThis Phase 3 trial tests a new drug called BL-B01D1 against standard chemotherapy in 538 people with advanced biliary tract cancer that has worsened after prior treatments. The goal is to see if the new drug helps people live longer. The study is not yet recruiting.
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis phase 1 trial is testing a new kind of CAR-T cell therapy, called LMY-922, for people with certain blood cancers that have not responded to standard treatments. The therapy uses donor immune cells engineered to target a protein called BAFF on cancer cells. The study aims to …
Phase: PHASE1 • Sponsor: Luminary Therapeutics • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One pill to tackle three heart risks: could a polypill cut cardiovascular disease?
Disease control Not yet recruitingThis trial tests whether a single daily pill that combines treatments for high blood pressure, high cholesterol, and type 2 diabetes can lower the risk of heart disease and dementia. The study involves over 8,000 adults aged 50 to 75 in China who have all three conditions. Partic…
Phase: NA • Sponsor: China Medical University, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New combo aims to fight merkel cell cancer when immunotherapy fails
Disease control Not yet recruitingThis study tests whether combining two drugs—ASTX727 (a pill) and retifanlimab (given through a vein)—can shrink tumors and control advanced Merkel cell cancer in people whose disease has worsened after standard immunotherapy. About 31 adults with stage III or IV Merkel cell canc…
Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Promising drug cocktail aims to shrink penile cancer before surgery
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy that attacks cancer cells with a specific protein) and Pucotenlimab (an immunotherapy that boosts the immune system)—in men with advanced penile cancer that is hard to treat with surgery al…
Phase: PHASE2 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple attack on lung scarring: could plasma exchange and immune therapy slow IPF?
Disease control Not yet recruitingThis Phase II trial tests whether a combination of therapeutic plasma exchange (filtering the blood), rituximab (a drug that targets certain immune cells), and intravenous immunoglobulin (IVIg) can slow lung decline in people with progressive idiopathic pulmonary fibrosis (IPF). …
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis phase 2 trial tests the drug mosunetuzumab in 30 people with chronic lymphocytic leukemia (CLL) who still have detectable cancer cells after at least six months of standard therapy. The goal is to see if the drug can clear those remaining cells and improve outcomes. Particip…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to preserve sight in rare genetic blindness
Disease control Not yet recruitingThis phase 3 trial tests whether NPI-001, taken twice daily for 24 months, can slow the loss of light-sensing cells in the eyes of adults with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 participants will receive either the drug or a pla…
Phase: PHASE3 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a common diabetes pill ease long COVID?
Disease control Not yet recruitingThis Phase 3 trial tests whether dapagliflozin, a drug used for diabetes, can improve quality of life in people with long COVID. 192 adults with persistent symptoms for at least 12 weeks after a COVID infection will receive either the drug or a placebo daily for 12 months. The ma…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can mindfulness lower blood pressure? new study investigates
Disease control Not yet recruitingThis study tests whether adding an 8-week online mindfulness program, called Mindfulness in Motion, to usual care helps people with high blood pressure improve their blood pressure, weight, stress, sleep, and well-being. Participants will be randomly assigned to either the mindfu…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a Pre-Chemo drug shield bone marrow in head and neck cancer?
Disease control Not yet recruitingThis trial tests whether giving trilaciclib before chemotherapy and immunotherapy can protect bone marrow in people with advanced head and neck cancer. The goal is to reduce dangerous drops in blood cell counts, allowing patients to receive their full chemo doses on schedule. Abo…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers with RAS mutations
Disease control Not yet recruitingThis study tests an experimental oral drug called GFH276 combined with either cetuximab or standard chemotherapy in people with advanced solid tumors or pancreatic ductal adenocarcinoma (PDAC) that have a RAS mutation. The goal is to see if the combination is safe, tolerable, and…
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug duo aims to wipe out leukemia cells in First-Line treatment
Disease control Not yet recruitingThis phase 2 trial tests two oral drugs, nemtabrutinib and venetoclax, as a first treatment for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to see if the combination can make cancer cells undetectable in the blood. About 25 adul…
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Dental visit could double as HIV test: study tests rapid screening in the Dentist's chair
Disease control Not yet recruitingThis study tests whether offering rapid HIV testing during a dental visit leads more people to get tested than simply referring them to a lab. About 6,700 adult dental patients at four community health centers will be offered either a quick oral swab test on-site or a referral fo…
Phase: NA • Sponsor: Boston University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Oxygen therapy may boost hip procedure for bone death
Disease control Not yet recruitingThis study tests whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to a standard hip procedure (core decompression with bone marrow cells) can reduce pain in people with early-stage avascular necrosis of the hip. The trial will enroll 400 p…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
A reversible gut sleeve could offer a new way to treat obesity
Disease control Not yet recruitingThis pilot study tests a temporary, flexible tube called a duodenal-jejunal bypass sleeve. It is placed in the upper intestine using an endoscope and left for 3 months to help with weight loss and improve metabolic syndrome. The study involves 20 adults with obesity or excess wei…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Targeted Antibody-Drug could shrink Hard-to-Treat ovarian cancers
Disease control Not yet recruitingThis trial tests a drug called sacituzumab govitecan in people with advanced or recurrent ovarian, fallopian tube, or primary peritoneal cancer that has high levels of a protein called TROP-2. Participants must have already tried standard treatments without success. The drug is g…
Phase: PHASE1 • Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New oral pill H021 aims to tame Crohn's Flare-Ups
Disease control Not yet recruitingThis phase 2 trial tests whether an experimental oral tablet called H021 can help people with moderate to severe Crohn's disease. Participants receive either a low or high dose of H021 or a placebo for 12 weeks, with an option to continue treatment. The study measures symptom imp…
Phase: PHASE2 • Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New eye drug targets fluid buildup to fight glaucoma
Disease control Not yet recruitingThis study tests an experimental drug called REGN22530 in people with primary open angle glaucoma or ocular hypertension. The drug is designed to block a protein in the eye that causes fluid buildup and high pressure. Researchers are checking for side effects, how the drug moves …
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Family-Wide dental treatment may break the cycle of oral infections
Disease control Not yet recruitingThis study investigates how bacteria that cause tooth decay and gum disease spread among family members. Researchers will treat either the child alone, the child and parents, or all family members with professional dental cleaning. They will track bacterial transmission using DNA…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Weight-Loss implant could replace weekly shots
Disease control Not yet recruitingThis early-stage study tests a small implant placed under the skin that releases semaglutide (the drug in Wegovy) over 4 weeks. It involves 20 otherwise healthy overweight or obese adults. The goal is to see if the implant is safe and how it compares to weekly injections.
Phase: PHASE1 • Sponsor: Vivani Medical, Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a common steroid save lives in severe lung failure?
Disease control Not yet recruitingThis study tests whether the steroid dexamethasone, when added to standard care, can lower the chance of death within 90 days for people with a serious lung condition called ARDS caused by sepsis. About 1,474 adults on breathing machines will take part. The goal is to see if this…
Phase: PHASE3 • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Radiotherapy revolution: could 5 sessions replace 25 for endometrial cancer?
Disease control Not yet recruitingThis trial explores whether a new type of radiotherapy called CT online-adaptive radiotherapy can safely deliver treatment for endometrial cancer in just 5 sessions over a week and a half, instead of the usual 25 sessions over 5 weeks. The study includes 30 adults who have had su…
Phase: NA • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Lab-Grown bladder patch could help patients with scarred bladders
Disease control Not yet recruitingThis early study is testing a new approach for people whose bladders have become small and scarred, causing frequent urination and discomfort. Doctors will take a small sample of the patient's own bladder cells, grow them in a lab on a special scaffold to create a 'neo-bladder' p…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a common acne drug help beat tough fungal infections?
Disease control Not yet recruitingThis study compares the standard antifungal drug itraconazole alone versus itraconazole combined with isotretinoin (an acne medication) in adults with tinea corporis or cruris (ringworm of the body or groin). The goal is to see if the combination shortens treatment time and impro…
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Digital exercise program aims to boost recovery for breast cancer survivors
Disease control Not yet recruitingThis trial tests a 12-week program called EmpowerHer that combines home-based exercise via a mobile app with weekly in-person group sessions. It aims to improve health-related quality of life, reduce fatigue, anxiety, and depression, and increase physical fitness in breast cancer…
Phase: NA • Sponsor: University of Valencia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New 3D lung mapping could replace needle punctures for small nodule surgery
Disease control Not yet recruitingThis trial tests a new method called Longitude-Latitude-Depth (LLD) localization, which uses 3D mapping from a CT scan to guide surgeons to small lung nodules without a needle puncture. It is being compared to the standard CT-guided needle localization in adults with single perip…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New insomnia drug HS-10506 put to the test in large safety trial
Disease control Not yet recruitingThis phase 3 study evaluates the safety of HS-10506, an experimental insomnia medication, in 600 Chinese adults aged 18 to 64 with insomnia disorder. Researchers track side effects, serious adverse events, and specific safety concerns over both short and long-term use. The goal i…
Phase: PHASE3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a phone app sharpen the minds of people with schizophrenia?
Disease control Not yet recruitingThis study tests a smartphone-based digital training program designed to improve working memory in people with schizophrenia or related disorders. Participants use the app to practice cognitive exercises, and researchers measure changes in memory and mental health. The goal is to…
Phase: PHASE1, PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New cocktail aims to tackle tough lymphoma
Disease control Not yet recruitingThis early-stage trial tests whether adding sonrotoclax to standard Pola-R-CHP chemotherapy can improve outcomes for people with untreated large B-cell lymphoma that has high BCL2 expression or double-hit features. The study has two parts: first, finding a safe dose of sonrotocla…
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could tailoring chemo by age make stem cell transplants safer for MDS patients?
Disease control Not yet recruitingThis study looks at two different chemotherapy combinations given before a half-matched stem cell transplant in adults with myelodysplastic syndrome (MDS). One regimen is designed for people aged 55 and older to reduce side effects, while the other is a standard stronger regimen …
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids: drug may prevent transplant complications
Disease control Not yet recruitingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood disorders who are getting a bone marrow transplant. GVHD is a serious complication where donor cells…
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Experimental pill aims to ease thick heart muscle symptoms
Disease control Not yet recruitingThis phase 2 trial tests an oral drug called Aom0304 in adults with hypertrophic cardiomyopathy, a condition where the heart muscle is abnormally thick. The study includes people with both obstructive and non-obstructive forms. Participants receive different doses of Aom0304 for …
Phase: PHASE2 • Sponsor: Amckaus PTY LTD. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Radiation boost may supercharge CAR T-Cell therapy against tough lymphoma
Disease control Not yet recruitingThis trial tests whether adding low-dose total body irradiation (TBI) to standard chemotherapy before CAR T-cell therapy (tisagenlecleucel) is safe and effective for adults with large B-cell lymphoma that has returned or not responded to prior treatments. The study involves 18 pa…
Phase: PHASE1 • Sponsor: Nathan Denlinger • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Heart drug study pulled before it even started
Disease control Not yet recruitingThis study aimed to see if a short course of the heart medication amiodarone could prevent atrial fibrillation (an irregular heartbeat) in adults after heart surgery. About 1 in 3 patients experience this complication. However, the study was withdrawn before enrolling any partici…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a diabetes drug slow breast cancer growth?
Disease control Not yet recruitingThis phase 2 trial investigates whether tirzepatide, a drug used for weight loss and diabetes, can slow tumor growth in people with early-stage hormone-receptor-positive breast cancer. Participants receive tirzepatide alone, the standard hormone therapy letrozole alone, or both t…
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New study tests better surgical fix for buried penis in boys
Disease control Not yet recruitingThis trial compares two surgical methods to fix buried penis in children under 18. One technique attaches the suspensory ligament to the skin; the other attaches it to the penile shaft. The goal is to see which approach has fewer complications and lower recurrence rates.
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Freezing breast tumors: a new hope for metastatic cancer control?
Disease control Not yet recruitingThis study investigates cryoablation, a procedure that freezes and destroys tumor tissue, for treating the primary breast tumor in women with metastatic breast cancer. The goal is to see if this minimally invasive approach can control the local tumor for 12 months while patients …
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to outperform standard therapy for advanced colorectal cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding the experimental drug SHR-A1811 to standard chemotherapy and bevacizumab works better than standard therapy alone for people with advanced colorectal cancer who have not had prior treatment. About 300 participants will receive either the ne…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New Stomach-Suturing device could help obese asians lose weight without surgery
Disease control Not yet recruitingThis study tests a device called OverStitch NXT, which uses sutures to reduce stomach size through an endoscope (a tube down the throat), avoiding traditional surgery. It involves 136 obese Asian adults with a BMI of 27.5 or higher, some with diabetes or other obesity-related con…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nasal spray ingredient may offer safer dental pulp treatment for kids
Disease control Not yet recruitingThis study tests whether oxymetazoline, a common nasal decongestant, can replace sodium hypochlorite as a bleeding control agent during pulp treatment in children's baby teeth. About 50 Egyptian children aged 4-8 with decayed molars will receive either treatment. The goal is to s…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Peer buddies may keep liver transplant patients off alcohol
Disease control Not yet recruitingThis study tests whether peer support specialists—people who have been through liver transplant for alcohol-related disease themselves—can help others in the same situation stay sober and attend medical appointments. About 95 participants will meet regularly with a peer supporter…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug iptacopan studied for rare kidney disease C3G
Disease control Not yet recruitingThis study looks back at the experiences of 35 adults with a rare kidney disease called C3G who received the drug iptacopan through a special early access program in Spain. Researchers will collect information on patient health, lab results, and how the disease responds to treatm…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New cancer drug candidate SHR-4685 enters first human tests
Disease control Not yet recruitingThis early-stage trial tests a new drug called SHR-4685 in people with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 170 adults aged 18 to 75 with meas…
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New TB cocktail aims to shorten treatment
Disease control Not yet recruitingThis study tests a new combination of three drugs—sorfequiline, pretomanid, and linezolid—in 100 adults with newly diagnosed, drug-sensitive tuberculosis. Participants take the pills daily for 17 weeks. The goal is to see if the combo is safe and can clear the infection faster th…
Phase: PHASE2 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a Light-Activated cream replace surgery for cervical precancer?
Disease control Not yet recruitingThis study tests a new approach for treating high-grade cervical precancer (HSIL) using a cream called HAL that is activated by a special light, instead of standard surgery. About 230 women will be randomly assigned to receive either the light therapy or surgery. The main goal is…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could simple strength exercises boost bone density in kids with cerebral palsy?
Disease control Not yet recruitingThis study investigates whether a program of functional progressive resistance training—exercises like sit-to-stand, step-ups, and stair climbing with gradually increasing resistance—can improve bone mineral density and balance in children with cerebral palsy. The trial includes …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New heart pump aims to make risky angioplasty safer
Disease control Not yet recruitingThis trial compares a new temporary heart pump called VentriCure with standard ECMO support in people with coronary artery disease undergoing high-risk angioplasty. The study includes 220 patients whose hearts are weak or who have severe heart failure. The goal is to see if Ventr…
Phase: NA • Sponsor: Life Shield Medical Technology Co., LTD • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New diabetes shot could cut injections to once a month
Disease control Not yet recruitingThis study tests a new, long-acting form of semaglutide (a diabetes drug) that is given once every four weeks instead of weekly. The goal is to see if it is safe and works well for controlling blood sugar and weight in 24 adults with type 2 diabetes. Participants must already be …
Phase: PHASE1, PHASE2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Off-the-Shelf immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-phase trial is testing an experimental therapy called GT737 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatment. GT737 uses specially engineered immune cells (iNKT cells) that are made in large batches and can be given…
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Massive heart failure platform trial aims to find better treatments
Disease control Not yet recruitingThis platform trial will enroll 1,000 adults with heart failure to test several different treatments at the same time. Participants are randomly assigned to either an experimental intervention or standard care. The main goal is to see if these treatments can prevent death or hosp…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to tame lupus kidney disease in kids
Disease control Not yet recruitingThis study tests whether combining rituximab with a low dose of mycophenolate mofetil can safely and effectively treat lupus nephritis in children. Lupus nephritis is a serious kidney complication of lupus. The trial enrolls children aged 3 to 18 with active kidney inflammation. …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New rapid tests aim to speed up ebola and lassa fever diagnosis
Diagnosis Not yet recruitingThis study evaluates two new diagnostic tests (FORTIFIEDx and DECIPHER) for detecting Ebola and Lassa viruses. Researchers will use stored blood and cheek swab samples from patients in Guinea to see how well these tests compare to the standard PCR method. The goal is to determine…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New PET tracer could spot hidden heart scarring in rare amyloidosis
Diagnosis Not yet recruitingThis study tests a special radioactive tracer called [68Ga]Ga-FAPI-46 for PET scans in 40 people with transthyretin cardiac amyloidosis (ATTR-CM), a condition where abnormal proteins build up in the heart. The goal is to see if this scan can measure scar-like activity in the hear…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New scan could spot hidden scarring in heart and lungs before It's too late
Diagnosis Not yet recruitingThis study tests a new radioactive tracer called 18F-FAPI-74 that may help detect scar tissue (fibrosis) in the heart and lungs earlier than current methods. Researchers will compare this new PET/CT scan to standard imaging in 210 adults with conditions like lung disease or heart…
Phase: PHASE3 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Laser and AI team up to spot lung cancer in minutes during surgery
Diagnosis Not yet recruitingThis trial investigates whether a femtosecond laser combined with an artificial intelligence model can diagnose lung cancer from fresh tissue samples as accurately as the standard frozen section method. About 294 adults scheduled for lung surgery will have their tumor specimens e…
Sponsor: Shanghai Chest Hospital • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Your bathroom scale could soon warn you about heart failure
Diagnosis Not yet recruitingThis study will test whether an algorithm that analyzes data from Withings smart scales (weight, body water, and step counts) can accurately detect heart failure. Researchers will look back at data from 9,000 people aged 45 and older in the US. If the algorithm works well, it cou…
Sponsor: Withings • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Sticker on the skin could replace scans for shunt checks
Diagnosis Not yet recruitingThis study tests a new wireless, noninvasive device called the Rhaeos Shunt Monitoring System (RSMS) that sticks to the skin to detect fluid flow in brain shunts used for hydrocephalus. About 85 children and adults with working shunts will have their shunt flow measured with both…
Phase: NA • Sponsor: Rhaeos, Inc. • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
AI learns to see burns on hands, head, and feet
Diagnosis Not yet recruitingThis study tests an AI-powered imaging device called DeepView to see if it can accurately assess burn injuries on the hands, head, and feet. Researchers will collect images from people with burns in these areas to train and improve the AI system. The goal is to help doctors make …
Sponsor: SpectralMD • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Simple test could slash use of Last-Resort antibiotics for UTIs
Diagnosis Not yet recruitingThis trial investigates whether a rapid test for antibiotic resistance genes (integrons) can help doctors choose narrower-spectrum antibiotics for hospitalized adults with urinary tract infections (UTIs). Participants must have had a recent infection with a resistant bacterium. T…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Brain scan breakthrough: amino acid PET may solve a tricky diagnosis dilemma
Diagnosis Not yet recruitingThis study tests whether a type of PET scan that tracks amino acids can accurately tell apart radiation necrosis (dead tissue from treatment) from tumor regrowth in people who have had radiation for brain metastases. About 80 patients who already received this PET scan will have …
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
Can a chatbot help end HIV? new study tests digital tool in black MSM
Prevention Not yet recruitingThis study will test a chatbot designed to increase awareness and use of PrEP, a daily pill that prevents HIV, among Black men who have sex with men (MSM) in the Southern United States. About 145 participants will interact with the chatbot over 90 days, answering questions and re…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Could a daily glass of kefir during pregnancy ward off gestational diabetes?
Prevention Not yet recruitingThis study investigates whether drinking kefir, a fermented dairy drink rich in live bacteria and yeasts, from around 14 weeks of pregnancy until routine diabetes screening can improve blood sugar control and reduce the risk of gestational diabetes. Pregnant individuals are rando…
Phase: NA • Sponsor: University of New Brunswick • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Texts that could transform trans teen sexual health
Prevention Not yet recruitingThis study tests a 5-month text-messaging program called #TranscendentHealth, created specifically for transgender boys and gender-diverse youth assigned female at birth, ages 14 to 18. The program aims to improve condom use, birth control use, and HIV/STI testing by addressing t…
Phase: NA • Sponsor: Center for Innovative Public Health Research • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingThis study tests whether a daily probiotic supplement called Colipral® can prevent repeat bladder infections (cystitis) in menopausal women aged 55–70. Participants take either the probiotic or a placebo for 12 weeks and are monitored for 24 weeks to see if they have fewer infect…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Can a new program outperform the gold standard in eating disorder prevention?
Prevention Not yet recruitingThis study compares two behavioral programs for young women aged 14-22: a new one called Priorities, which helps build self-worth beyond weight and shape, and The Body Project, an established eating disorder prevention program. Researchers want to see which is more effective at r…
Phase: NA • Sponsor: Stanford University • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Simple antibacterial wash could slash deadly graft infections in vascular surgery
Prevention Not yet recruitingThis study tests whether washing the surgical wound and the new prosthetic graft with a hypochlorous acid solution at the end of surgery can prevent infections. Participants are adults having open surgery to insert a synthetic bypass graft for narrowed or blocked arteries. The st…
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Night shift workers get tailored cancer prevention plan in new study
Prevention Not yet recruitingThis study tests whether a personalized prevention plan helps female night shift workers reduce their breast cancer risk. Night shift work is linked to higher cancer risk due to disrupted sleep cycles. One hundred women at a Paris hospital will receive tailored advice on diet, ex…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Migraine drug may stop altitude sickness before it starts
Prevention Not yet recruitingThis study tests whether a single injection of fremanezumab, a drug used to prevent migraines, can stop acute mountain sickness (AMS) in healthy adults. Thirty volunteers will receive either the drug or a placebo one week before climbing to a high-altitude hut. Researchers will t…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Dirt floors linked to infant deaths? simple fix could save lives
Prevention Not yet recruitingThis study tests whether replacing soil floors with concrete floors in rural Bangladeshi homes can reduce stillbirths and deaths in the first month of life. Researchers will compare 196 households that received concrete floors to those that kept soil floors, tracking pregnancies …
Phase: NA • Sponsor: Stanford University • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Digital sleep therapy aims to stop depression before it starts in young adults
Prevention Not yet recruitingThis study tests whether a digital program that combines cognitive behavioral therapy for insomnia with circadian rhythm coaching can prevent depressive symptoms from worsening in college students aged 18-24 who have trouble falling asleep and tend to be night owls. Participants …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New screening strategy aims to catch colorectal cancer early in younger veterans
Prevention Not yet recruitingThis study tests whether a multilevel screening program can increase colorectal cancer screening rates among Veterans aged 45-49, an age group now recommended for screening due to rising early-onset cases. Participants are randomly assigned to receive a patient education letter a…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Mailed test strips aim to slash opioid overdose deaths
Prevention Not yet recruitingThis study tests whether sending fentanyl test strips by mail and providing online education can reduce opioid overdoses. Researchers will enroll 100 adults who use opioids or stimulants and live in states where test strips are legal. The goal is to find the most effective and lo…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple 14-day heart monitor patch prevent strokes in at-risk seniors?
Prevention Not yet recruitingThis study investigates whether screening older veterans (age 65 and older) who have a higher risk of atrial fibrillation—a condition where the heart beats irregularly—can reduce their chances of stroke, heart failure, or death. Participants selected for screening wear a small, w…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Can a common arthritis drug stop Parkinson's before it starts?
Prevention Not yet recruitingThis study tests whether adalimumab, an anti-inflammatory drug, can prevent brain changes linked to Parkinson's disease in 108 people with REM sleep behavior disorder (RBD). RBD often precedes Parkinson's. Participants will receive adalimumab or a placebo every two weeks for two …
Phase: PHASE2 • Sponsor: Yale University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New behavioral program aims to curb HIV and drug use in High-Risk men
Prevention Not yet recruitingThis study tests a six-session behavioral program for stimulant-using men at high risk for HIV. The program focuses on positive thinking, mindfulness, and building supportive networks to help participants start taking PrEP (a daily pill that prevents HIV) and reduce stimulant use…
Phase: NA • Sponsor: University of Florida • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Could a nerve block boost frozen shoulder treatment?
Symptom relief Not yet recruitingThis study compares two treatments for frozen shoulder (retractile capsulitis): a standard steroid injection into the shoulder joint versus that same injection plus a nerve block near the shoulder blade. The nerve block uses a numbing medicine and a steroid to calm the nerve that…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a smartphone app help people track and understand chronic pain?
Symptom relief Not yet recruitingThis study tests a mobile app called DockTales, designed for adults with chronic pain. The app lets users track pain and sleep through short diaries, body maps, and journaling, with an optional AI feature for reflection. Researchers want to see if the app is easy to use and engag…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could ozone therapy ease fibromyalgia pain and fatigue?
Symptom relief Not yet recruitingThis study investigates whether major ozone autohemotherapy — a procedure where a small amount of blood is mixed with ozone and returned to the body — can improve pain, fatigue, sleep, and muscle health in women with fibromyalgia. Sixty participants will receive either exercise a…
Phase: NA • Sponsor: Sakarya University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Smartphone therapy may ease anxiety for those with disabilities
Symptom relief Not yet recruitingThis study tests whether a mobile app that combines digital cognitive behavioral therapy (CBT) with personal mental health coaching can reduce anxiety in adults with hearing or mobility disabilities. Participants use either the active program or a sham version for 8 weeks, with f…
Phase: NA • Sponsor: Toivoa Inc • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
When to zap? new trial seeks optimal timing for brain stimulation after stroke
Symptom relief Not yet recruitingThis study tests whether giving a mild electrical brain stimulation (tDCS) before, during, or after physical therapy helps stroke patients recover arm movement faster. Sixty hospitalized stroke survivors will receive three daily tDCS sessions, with only one being real and the oth…
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Band workouts and breathing drills may boost lung health in seniors
Symptom relief Not yet recruitingThis study looks at whether elastic-band resistance training, with or without breathing exercises, can improve lung function and physical abilities in older adults with mild breathing problems. Seventy-five people aged 60 to 85 will be randomly assigned to one of three groups: re…
Phase: NA • Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Soothing sounds for sensitive stomachs: music therapy tested for IBS pain
Symptom relief Not yet recruitingThis pilot study from Yale University will test whether listening to calming, instrumental music can reduce pain and stress in people with irritable bowel syndrome (IBS). Thirty adults with moderate IBS pain will listen to pre-recorded playlists for 20 minutes twice a day, five d…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could light therapy ease Chemo's nerve pain?
Symptom relief Not yet recruitingThis trial investigates whether photobiomodulation (low-level laser light) can reduce early nerve damage caused by chemotherapy. About 98 cancer patients with early signs of peripheral neuropathy will receive either light therapy or a placebo. The goal is to see if this non-invas…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Sugar solution may rival steroids for stuck fingers
Symptom relief Not yet recruitingThis study compares two ultrasound-guided injections for trigger finger, a condition where a finger gets stuck in a bent position. One injection uses betamethasone (a steroid), the other uses dextrose (a sugar solution). The goal is to see if dextrose, which may help tissue heal,…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New nerve block aims to cut opioid use after gallbladder surgery
Symptom relief Not yet recruitingThis study tests whether a specific nerve block, called the rectointercostal plane block (RICPB), can reduce pain and the need for strong painkillers after gallbladder removal surgery. Sixty adults scheduled for laparoscopic cholecystectomy will receive either the RICPB or standa…
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a daily cup of green tea extract ease cancer nerve pain?
Symptom relief Not yet recruitingThis study tests whether taking a daily capsule of decaffeinated green tea extract can reduce nerve pain in people who have had cancer treatment. The trial enrolls 20 adults with stable pain who are not currently undergoing cancer therapy. Participants receive either the green te…
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
VR headset beats Pre-Surgery jitters in new trial
Symptom relief Not yet recruitingThis study tests whether a virtual reality (VR) session the day before gallbladder surgery can lower patients' anxiety and uncertainty about general anesthesia. Two hundred adults who have never had anesthesia will either watch a VR video showing the operating room and anesthesia…
Phase: NA • Sponsor: Mackay Memorial Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Migraine drug tested for Long-Term safety in 1,000-Person trial
Symptom relief Not yet recruitingThis phase 3 study evaluates the long-term safety of elismetrep (K-304), an oral medication taken as needed for migraine attacks. About 1,000 adults who previously took elismetrep in an earlier trial will continue using it intermittently. Researchers will track side effects over …
Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone app help teens kick the vape habit?
Symptom relief Not yet recruitingThis study tests whether a smartphone app with AI can help adolescents aged 14-20 quit e-cigarettes. Participants use the app to set goals, track progress, and get real-time support during cravings. Researchers compare an immediate-use group with a delayed-start group to see if t…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New study tests if helping others can spark motivation in dementia patients
Symptom relief Not yet recruitingThis study tests two simple activities—volunteering inside the assisted living community or joining a current events discussion group—to see if they can reduce apathy in residents with mild to moderate memory problems. About 200 people aged 55 and older will take part for 6 month…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Online Mind-Body program aims to ease infertility stress
Symptom relief Not yet recruitingThis study tests a web-based mind-body awareness program for women undergoing infertility treatment. The program includes education and relaxation practices over 3 sessions in 2 weeks. Researchers will measure if it improves fertility awareness and feelings of preparedness in 78 …
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Cancer drug keytruda tested as possible treatment for long COVID brain fog
Symptom relief Not yet recruitingThis early-stage trial tests whether a single dose of pembrolizumab (Keytruda), a drug used for cancer, can safely reduce long-term neurological symptoms like brain fog and dizziness in people with long COVID. Fifteen adults who had COVID-19 at least six months ago and still have…
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Massage during chemo: a new way to ease cancer treatment stress?
Symptom relief Not yet recruitingThis small study will test whether giving a 15-20 minute massage during infusion therapy can reduce pain and anxiety in women with gynecologic cancer. Twenty-four participants will be randomly assigned to receive either a hand, foot, or neck/shoulder massage or simply talk with t…
Phase: NA • Sponsor: Jill Cole • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New study aims to find best therapy for angry outbursts in kids
Symptom relief Not yet recruitingThis study compares three types of therapy for children aged 8 to 16.5 with severe irritability. Participants will receive either exposure-based cognitive behavioral therapy, parent management training, or supportive psychoeducation over 12 sessions. The goal is to see which appr…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Herbal supplement cistanche tested for explosive power and recovery in athletes
Symptom relief Not yet recruitingThis study tested whether taking a cistanche supplement for 8 weeks, along with a supervised training program, improves anaerobic exercise performance and recovery in young men. 56 men aged 18-25, either elite or amateur athletes, were randomly assigned to receive cistanche extra…
Phase: NA • Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a daily probiotic be safe for Alzheimer's? new study aims to find out
Symptom relief Not yet recruitingThis Phase 2 trial will test whether taking a daily probiotic supplement for six months is safe and practical for people with early Alzheimer's or those at risk. Researchers will enroll 40 participants aged 60 and older. The study does not test whether the probiotic improves memo…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a 5-Day brain stimulation blitz ease depression in PTSD?
Symptom relief Not yet recruitingThis pilot study tests whether a faster schedule of non-invasive magnetic brain stimulation, called accelerated intermittent theta burst stimulation (iTBS), is practical and safe for adults with both PTSD and major depression. Participants receive six short sessions per day for f…
Phase: NA • Sponsor: Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Ketone drink may ease opioid withdrawal, new study suggests
Symptom relief Not yet recruitingThis study tests whether a ketone supplement drink can reduce cravings and withdrawal symptoms in adults with opioid use disorder who are undergoing detox in a treatment center. Fifty participants will receive either the ketone drink or a placebo three times daily for seven days.…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Healing sounds and virtual worlds may replace sedatives in heart cath labs
Symptom relief Not yet recruitingThis pilot study explores whether non-drug strategies like virtual reality or relaxing soundscapes can reduce anxiety and pain in adults undergoing scheduled coronary angiography or angioplasty. Participants will be assigned to listen to calming sounds, experience a virtual reali…
Phase: NA • Sponsor: Olivier F. Bertrand • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Exercise may counteract side effects of prostate cancer hormone therapy
Symptom relief Not yet recruitingThis trial investigates whether a supervised program of aerobic and strength training can improve quality of life, heart function, and body composition in men with prostate cancer who are receiving androgen deprivation therapy (hormone therapy). The study involves 46 men aged 40 …
Phase: NA • Sponsor: Universidade Federal de Santa Catarina • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Virtual reality may soothe teen anxiety during clinic visits
Symptom relief Not yet recruitingThis study tests whether a 15-20 minute virtual reality (VR) relaxation session can reduce anxiety in adolescents aged 12 to 18 during a primary care visit. Participants use the Healthy Mind® VR platform to explore calming environments like beaches or mountains while doing guided…
Phase: NA • Sponsor: Mohammed Bin Rashid University of Medicine and Health Sciences • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Magnetic pulses to the brain may ease neck dystonia symptoms
Symptom relief Not yet recruitingThis study investigates whether a type of noninvasive brain stimulation called continuous theta-burst stimulation (cTBS) can reduce symptoms of cervical dystonia, a condition that causes involuntary muscle contractions in the neck and head. Participants receive either real or sha…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Pinhole contact lens aims to sharpen sight for two eye conditions
Symptom relief Not yet recruitingThis early study tests a special contact lens that has a tiny pinhole built in. The idea is that the pinhole helps focus light better, improving vision for people with presbyopia (age-related blurry near vision) or keratoconus (a cone-shaped cornea). Sixteen adults will try the l…
Phase: NA • Sponsor: Azalea Vision • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail aims to soothe ICU delirium and prevent breathing tubes
Symptom relief Not yet recruitingThis study tests whether a combination of two sedatives, esketamine and dexmedetomidine, can better control agitation and shorten delirium in intensive care unit (ICU) patients who are on non-invasive breathing support. The trial will enroll 388 adults with hyperactive delirium a…
Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a simple supplement boost knee injection results for arthritis sufferers?
Symptom relief Not yet recruitingThis study tests whether adding an oral supplement (PEA) to a series of knee injections (adelmidrol and hyaluronic acid) can better reduce pain and improve function in people with knee arthritis. The injections aim to protect the joint from damage, while the supplement may help c…
Phase: NA • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone app help tame IBD symptoms?
Symptom relief Not yet recruitingThis pilot study will test a 24-week digital self-management program designed to help people with inflammatory bowel disease (IBD) manage their symptoms and build long-term healthy habits. The program is accessed via web or mobile device and is used alongside standard care. The s…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a common supplement ease long COVID in teens?
Symptom relief Not yet recruitingThis study investigates whether taking taurine—a natural amino acid found in the body and sold as a supplement—can help adolescents aged 10 to 17 who have Long COVID. Researchers will measure taurine levels in the blood and track changes in symptoms like fatigue, brain fog, and m…
Phase: PHASE1, PHASE2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Food as medicine: keto diet tested for bipolar disorder in rural south
Symptom relief Not yet recruitingThis pilot study will test whether a high-fat, low-carbohydrate ketogenic diet can reduce symptoms of bipolar disorder when added to standard treatments. The study will enroll 100 adults in rural Alabama and measure changes in mania severity. The goal is to see if a dietary appro…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Targeted magnetic pulses aim to lift bipolar depression
Symptom relief Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called rTMS can improve depression in people with bipolar disorder. Researchers use brain scans to create a personalized map for each participant, targeting the exact brain circuits involved in mood shifts. Parti…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone app improve cancer care? new study tests personalized nutrition and activity guidance
Symptom relief Not yet recruitingThis study will test whether a mobile app called RestoreMe can help cancer patients get personalized nutrition and activity advice. Researchers plan to enroll 150 adults who are about to start, are currently receiving, or have completed cancer treatment. Participants will use the…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New radiation method aims to shrink large tumors
Symptom relief Not yet recruitingThis pilot study tests whether adding a specialized radiation technique called Lattice Radiation Therapy (LRT) to standard palliative radiation can safely shrink large tumors (at least 4.5 cm) in adults. The study will enroll 25 people with various cancers who are already schedul…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Magnetic pulses to the brain may tame OCD symptoms
Symptom relief Not yet recruitingThis study tests whether a device that sends magnetic pulses to a specific brain area (dorsomedial prefrontal cortex) can safely reduce obsessive-compulsive behaviors in adults aged 22 and older. Participants receive either real or sham stimulation over six visits. The main goal …
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New pill aims to stop chronic hives fast when antihistamines fail
Symptom relief Not yet recruitingThis early-phase trial tests a new drug called TLL-018 in 36 adults with moderate-to-severe chronic spontaneous urticaria (hives) that standard antihistamines can't control. The goal is to see how quickly TLL-018 reduces itching and hives after the first dose. Participants will r…
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New hope for bipolar depression? pramipexole trial targets anhedonia
Symptom relief Not yet recruitingThis Phase 3 trial tests whether pramipexole, a dopamine-boosting drug, can ease anhedonia (loss of pleasure) in people with bipolar depression. 126 participants will receive either pramipexole or a placebo alongside their usual mood stabilizer for 6 weeks. The study aims to impr…
Phase: PHASE3 • Sponsor: Daniel Lindqvist • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Zapping the brain to sleep better and seize less
Symptom relief Not yet recruitingThis study tests a non-invasive technique called temporal interference stimulation to boost deep sleep in people with epilepsy. Researchers will compare 4 nights of real stimulation to 4 nights of sham (fake) stimulation in up to 16 patients. The goal is to see if better sleep ca…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a muscle relaxant make newborn intubation safer?
Symptom relief Not yet recruitingThis study tests whether adding a muscle relaxant (rocuronium) to standard painkiller (fentanyl) helps doctors place breathing tubes in newborns on the first try, without causing dangerous drops in oxygen or heart rate. About 102 premature or sick babies in a Brazilian NICU will …
Phase: PHASE4 • Sponsor: UEA - Universidade Do Estado Do Amazonas • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New training aims to help prostate cancer patients speak up about sexual health
Symptom relief Not yet recruitingThis pilot study tests a communication skills training program called Starting the Conversation for prostate cancer patients who are bothered by sexual problems. About 100 men will either receive the training or a general health education program. The goal is to see if the traini…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New portable device could speed leg wound healing after skin cancer surgery
Symptom relief Not yet recruitingThis study tests a small, portable device called SNaP that uses gentle suction to help surgical wounds on the lower legs heal faster after Mohs surgery for skin cancer. About 60 adults aged 19-79 with lower leg wounds will either use the SNaP device or receive standard wound care…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can core workouts cure leaky bladder? new study investigates
Symptom relief Not yet recruitingThis study tests whether adding core muscle exercises to standard pelvic floor training can better reduce urinary incontinence. Fifty adults with stress or mixed incontinence will do 12 weeks of exercises, either standard or with core co-activation. Researchers will measure sympt…
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a video call replace the physio clinic for neck pain?
Symptom relief Not yet recruitingThis study tests whether doing physiotherapy at home through live video calls works as well as going to a clinic for people with moderate neck pain from cervical spondylosis. Fifty-two adults aged 45-64 will be split into two groups: one gets in-person sessions, the other gets re…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New device aims to speed up breast reconstruction surgery
Symptom relief Not yet recruitingThis study tests a device called ORASIS, which helps keep the surgical area clean during DIEP flap breast reconstruction. The device automatically removes fluid and smoke, so the surgeon can work without pausing. The trial will include 30 women who have had a mastectomy and are g…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New radiation technique aims to shield airways and preserve lung function
Symptom relief Not yet recruitingThis trial compares standard radiation therapy with a new method that specifically avoids damaging small airways in the lungs. The goal is to see if this airway-sparing approach helps patients with stage III non-small cell lung cancer retain better breathing function after treatm…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a common numbing drug cut Post-Surgery opioid use?
Symptom relief Not yet recruitingThis study tests whether giving lidocaine through an IV, along with a spinal morphine injection, can lower the amount of morphine patients need after major digestive or abdominal surgery. About 76 adults having planned open abdominal surgery will be randomly assigned to receive e…
Phase: PHASE3 • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a phone app lift depression? 1,500 volunteers test a meditation program
Symptom relief Not yet recruitingThis trial investigates whether the Healthy Minds Program, a mobile meditation training app, can reduce symptoms of depression in adults. About 1,500 participants with elevated depressive symptoms will complete a 4-week well-being program using the app. Researchers will measure c…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
AI coach could help fibromyalgia patients exercise at home
Symptom relief Not yet recruitingThis study tests whether an artificial intelligence (AI) and computer vision system can help people with fibromyalgia perform effective exercise at home. Participants use a smartphone or tablet app that watches their movements and gives real-time feedback, with or without added r…
Phase: NA • Sponsor: Instituto Neurociencia Del Dolor • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Simple pressure check may spare kids from post-surgery sore throat
Symptom relief Not yet recruitingThis study compares two ways of adjusting the air cushion (cuff) on the breathing tube used during general anesthesia in children having laparoscopic appendectomy. One group uses the standard finger-palpation method, while the other uses a pressure sensor to keep the cuff within …
Phase: NA • Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Mindfulness may help caregivers move more and reduce heart risks
Symptom relief Not yet recruitingThis study tests a brief mindfulness-based lifestyle program for caregivers of people with neurodegenerative disorders like Alzheimer's or Parkinson's. Many caregivers are not physically active, raising their risk for heart disease. The program combines in-person group sessions w…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a common blood pressure drug be the key to pain-free hemorrhoid recovery?
Symptom relief Not yet recruitingThis study tests whether taking oral nifedipine, a drug usually used for high blood pressure, can reduce pain and improve wound healing after hemorrhoid removal. One hundred adults in Yemen will receive either nifedipine or a placebo twice daily for two weeks after surgery. Resea…
Phase: PHASE4 • Sponsor: Sana'a University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could virtual reality help patients recover faster from cell therapy?
Symptom relief Not yet recruitingThis study tests whether using an immersive virtual reality headset during exercise can improve motivation, adherence, and emotional well-being in adults undergoing cell therapy or stem cell transplant. Participants follow a therapeutic exercise program with or without VR. The tr…
Phase: NA • Sponsor: Fundacin Biomedica Galicia Sur • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can coaching and education ease chronic back pain without pills?
Symptom relief Not yet recruitingThis trial tests a program called ENCompaSS that combines education, phone coaching, and self-management tips to help Veterans with long-term back pain. Participants are randomly assigned to either the program plus usual care or usual care alone. The study measures whether the pr…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New injection could ease pain after knee replacement
Symptom relief Not yet recruitingThis study tests whether adding a simple numbing injection (SSSI) to standard pain blocks can better control pain after knee replacement surgery. About 90 adults aged 45-90 will be randomly assigned to receive either the extra injection or a sham (fake) one. The main goal is to s…
Phase: NA • Sponsor: Taipei Medical University WanFang Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Heart patients get a coach: will it keep them healthier?
Symptom relief Not yet recruitingThis study looks at whether 12 virtual health coaching sessions over 16 weeks can help people with heart disease (like heart failure or a heart attack) improve their health, reduce stress, and lower the chance of going back to the hospital. About 70 adults will take part, and the…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Ear nerve zaps may lift depression in Parkinson's
Symptom relief Not yet recruitingThis study tests whether a small device that gently stimulates a nerve in the ear can help reduce depression in people with Parkinson's disease. Participants use the device at home twice a day for 14 days. The trial measures changes in mood and brain activity to see if this simpl…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Tuning in to relief: music therapy app tested for sickle cell pain
Symptom relief Not yet recruitingThis study will test whether a 4-week daily music therapy app can reduce chronic pain and improve quality of life in 25 youth with sickle cell disease. Participants will either use the app or receive standard educational materials. Researchers will also look at changes in immune …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a lotus seed extract help menopausal women sleep through the night?
Symptom relief Not yet recruitingThis study tests whether a daily capsule containing lotus seed and rice germ extract, called ZenRest™, can improve sleep quality in menopausal women aged 40 to 65 who have mild-to-moderate sleep problems. Participants take either the supplement or a placebo for six weeks, and sle…
Phase: NA • Sponsor: Nutraland USA, Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a phone app lift depression? small study aims to find out
Symptom relief Not yet recruitingThis pilot study will test whether a mobile phone app can help reduce depression symptoms in African American adults. Eight participants will attend six weekly 90-minute classes through the app and complete surveys over four months. The goal is to see if this approach is effectiv…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a custom Tune-Up make music sound better for hearing aid users?
Symptom relief Not yet recruitingThis study tests a personalized music program for people who wear hearing aids but are unhappy with how music sounds. Researchers will create a custom frequency profile for each participant and add it to their hearing aids as a dedicated music setting. The trial includes 66 adult…
Sponsor: Institut Pasteur • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
A simple video before surgery may ease nerves — no pills needed
Symptom relief Not yet recruitingThis study tests whether watching a short educational video before surgery can lower anxiety in adults having elective procedures. Participants are randomly assigned to receive the video via a QR code they scan on their own phone, via a tablet provided in the waiting area, or to …
Phase: NA • Sponsor: Aksaray University Training and Research Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New cream with plant extract aims to heal Incontinence-Related skin damage
Symptom relief Not yet recruitingThis study tests a new barrier cream (Dermategrity "Anti-fecal" Barrier Cream) that contains zinc oxide and a natural plant extract to protect and heal skin damaged by incontinence. Sixty adults with incontinence-associated dermatitis will receive either the new cream or a standa…
Phase: NA • Sponsor: Scotiaderm • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New eye drop aims to soothe dry eyes from too much screen time
Symptom relief Not yet recruitingThis study compares a new eye drop (perfluorohexyloctane) with a standard one (sodium hyaluronate) for people whose eyes get dry from using screens for more than 6 hours a day. Participants aged 18 to 70 with mild to moderate dry eye will use the drops four times daily for 8 week…
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New nerve block may ease shoulder surgery pain without affecting breathing
Symptom relief Not yet recruitingThis study will compare two types of nerve blocks for pain relief after shoulder surgery. One is a standard block that can sometimes weaken breathing; the other is a newer block that may avoid that side effect. 120 adults having shoulder arthroscopy will be randomly assigned to o…
Phase: NA • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New injection could tame teen hay fever
Symptom relief Not yet recruitingThis study tests whether an injection called stapokibart can reduce nasal allergy symptoms like runny nose, congestion, sneezing, and itching in adolescents aged 12 to 17 with seasonal allergic rhinitis (hay fever). Participants receive either stapokibart or a placebo alongside t…
Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
A 45-Minute talk after childbirth could cut postpartum depression risk
Symptom relief Not yet recruitingThis study tests whether a structured, midwife-led review of the childbirth experience can improve mental health in new mothers and fathers. The intervention involves a 45-60 minute session where parents discuss their birth story, receive emotional support, and get clarifications…
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Olive oil swish might cut asthma drug side effects
Symptom relief Not yet recruitingThis study tests whether an extra virgin olive oil and water mouthwash can remove more leftover asthma medication from the mouth than plain water. The medication residue can cause problems like thrush or sleep apnea. Twenty healthy adults and adults with asthma will rinse with di…
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Simple breathing workouts may help breast cancer patients breathe easier after surgery
Symptom relief Not yet recruitingThis study looks at whether doing special breathing exercises for at least two weeks before breast cancer surgery can keep the breathing muscles strong. About 40 adults recently diagnosed with breast cancer will either do breathing muscle training or guided imagery exercises at h…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Simple patch may ease stomach bloating after heart surgery
Symptom relief Not yet recruitingThis study tests whether an anti-bloating patch can reduce stomach swelling after heart surgery. Stomach bloating is common after cardiac procedures and can slow recovery. The trial will compare standard care alone to standard care plus the patch in 150 adults undergoing elective…
Phase: NA • Sponsor: Southeast University, China • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can sound or talk therapy silence the ringing in your ears?
Symptom relief Not yet recruitingThis study compares sound therapy, cognitive behavioral therapy (CBT), and their combination to help people with chronic tinnitus (ringing in the ears). Sixty adults aged 18-65 with stable health will be randomly assigned to one of three groups for six weeks. The goal is to see w…
Phase: NA • Sponsor: Sohag University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
AI coach for parents of diabetic kids: will it make carb counting easier?
Symptom relief Not yet recruitingThis study tests whether an AI-powered educational platform can help parents of children with type 1 diabetes count carbohydrates more accurately and manage diabetes better. About 80 parents will either use the AI platform plus usual care or usual care alone for 12 weeks. The goa…
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a new pill tame Autism-Related irritability in kids?
Symptom relief Not yet recruitingThis Phase 3 study tests whether a combination of two drugs, KarXT and KarX-EC, can safely reduce irritability in children and adolescents aged 5 to 17 with autism spectrum disorder. About 176 participants will receive either the drug combo or a placebo for 8 weeks. The main goal…
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Hope for families: new drug trial targets autism irritability in kids
Symptom relief Not yet recruitingThis study tests whether a new medication, KarXT + KarX-EC, can reduce irritability in children and teens (ages 5 to 17) with autism. About 176 participants will receive either the drug or a placebo. The main goal is to see if the drug improves irritability scores after 8 weeks.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New study aims to cut opioid use after knee replacement with targeted nerve blocks
Symptom relief Not yet recruitingThis trial compares three ways to manage pain after total knee replacement. All patients receive standard nerve blocks, but some also get an anti-inflammatory drug (dexamethasone) or a combination of dexamethasone and a sedative (dexmedetomidine). The goal is to see which approac…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a 5-Minute mindfulness text ease pain after joint replacement?
Symptom relief Not yet recruitingThis study tests whether a short mindfulness exercise, followed by questions that help patients reflect on their experience, can reduce pain and anxiety after knee or hip replacement surgery. Adults who have had a joint replacement will receive a guided breathing exercise via tex…
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New study tests which laser technique clears kidney stones faster
Symptom relief Not yet recruitingThis study compares two ways to break up kidney stones using a laser and a suction device. One method turns stones into dust, the other into small fragments. The goal is to see which leaves fewer stone pieces behind after one month. About 86 adults with small kidney stones will t…
Phase: NA • Sponsor: Bir Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Massage vs stretch: which eases piriformis pain better?
Symptom relief Not yet recruitingThis study compares two manual therapy techniques—myofascial release and post-isometric relaxation—for treating piriformis syndrome, a condition where a muscle in the buttock presses on the sciatic nerve, causing pain, numbness, and tingling. Twenty-six adults aged 20 to 50 with …
Phase: NA • Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Nasal fentanyl spray could ease painful eye exams for premature babies
Symptom relief Not yet recruitingThis trial tests whether a fentanyl nasal spray can reduce pain during eye exams for retinopathy of prematurity (ROP) in preterm infants. About 58 babies born at or before 31 weeks will receive either fentanyl or a saltwater placebo before their routine exam, along with standard …
Phase: PHASE1, PHASE2 • Sponsor: Marsha Campbell-Yeo • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Platelet transfusions may influence blood vessel health in critically ill patients
Knowledge-focused Not yet recruitingThis study investigates how platelet transfusions affect the function of small blood vessels and inflammation in intensive care patients with low platelet counts. Researchers measure blood vessel response using a laser device on the skin and track levels of various biomarkers in …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Social media meets medicine: could instagram and podcasts help fight breast cancer?
Knowledge-focused Not yet recruitingThis study tests whether an 8-week program using Instagram posts and podcast episodes can improve breast cancer awareness and screening habits in women aged 20 to 39. Participants follow a dedicated Instagram account and listen to podcast content designed to educate about symptom…
Phase: NA • Sponsor: Ankara University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists trace heart failure drug's path through the body
Knowledge-focused Not yet recruitingThis Phase 1 trial investigates how the drug HRS-9057 is absorbed, processed, and eliminated in healthy men. Six participants receive a single dose, and researchers measure the drug and its breakdown products in blood, urine, and stool. The goal is to understand the drug's behavi…
Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Family workouts may boost brain power: study tests Mother-Child exercise effects on cognition
Knowledge-focused Not yet recruitingThis pilot study investigates whether exercising together or separately influences brain function, cognitive performance, mood, and parent-child connection in mother-child pairs. Mothers and their children (ages 4-12) will complete two fitness sessions—one together and one in sep…
Phase: NA • Sponsor: Penn State University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Your voice in the tumor board: study tests if patient reports lead to better cancer treatment
Knowledge-focused Not yet recruitingThis study will include about 2,748 people with breast, gynecologic, or pancreatic cancer. Researchers want to see if adding patient-reported outcomes—like symptoms, preferences, and travel distance—to tumor board discussions helps doctors make better treatment decisions. The goa…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
World's largest Real-World CGM study aims to unlock diabetes management secrets
Knowledge-focused Not yet recruitingThis global registry study follows 5,000 people with diabetes who use a Dexcom continuous glucose monitor (CGM). Researchers will track changes in HbA1c, a key measure of blood sugar control, over time. The goal is to understand how CGM use affects diabetes management in real-wor…
Sponsor: DexCom, Inc. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New study tracks pregnancy risks for elafibranor users
Knowledge-focused Not yet recruitingThis study follows people who took elafibranor shortly before or during pregnancy to see if it affects the baby or mother. Researchers will collect information from medical records and safety reports over about 10 years. No extra tests or treatments are required—only routine care…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New HIV prevention drug faces drug interaction test
Knowledge-focused Not yet recruitingThis early-stage study looks at how a common tuberculosis drug, rifampin, affects levels of a new HIV prevention medicine called MK-8527. Fourteen adults with latent TB (no active symptoms) will take MK-8527 with and without rifampin. The goal is to see if the two drugs can be us…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Prostate device may cut need for repeat surgery
Knowledge-focused Not yet recruitingThis study looks at men with an enlarged prostate who previously used the ProVee urethral expander device. Researchers want to see if these men needed any additional surgical treatments after the device was removed. The goal is to understand how well the device works over the lon…
Sponsor: ProVerum Medical • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Dutch hospital data reveals hidden patterns in IBD treatment
Knowledge-focused Not yet recruitingThis study looks at medical records from thousands of adults with Crohn's disease or ulcerative colitis treated in Dutch hospitals between 2018 and 2026. Researchers will analyze which treatments patients receive, how often they switch therapies, and how the disease affects other…
Sponsor: LOGEX • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Mystery device trial: what we know so far
Knowledge-focused Not yet recruitingThis trial is testing a device that has not been approved by the U.S. FDA. The purpose is to gather information about how the device works in people. Participants will be monitored for safety and any effects. The study is still ongoing, and details about who can join are not yet …
Phase: NA • Sponsor: Toivoa Inc • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Blood test timing could unlock secrets of advanced breast cancer
Knowledge-focused Not yet recruitingThis study looks at how the timing of a blood test that detects tumor DNA (ctDNA) affects understanding of prognosis and treatment choices in people with advanced HR+/HER2- breast cancer. Researchers will follow 400 participants to see how ctDNA levels and gene mutations relate t…
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Weekly scans may make proton therapy safer for kids with cancer
Knowledge-focused Not yet recruitingThis study will enroll 100 children with solid tumors or Hodgkin lymphoma who are receiving proton therapy. Researchers will take weekly or bi-weekly CT or MRI scans during treatment to check if the original radiation plan is still accurate. If tumor coverage drops by 5% or radia…
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists hunt for fingerprints of a genetic form of Parkinson's
Knowledge-focused Not yet recruitingThis study aims to find unique biological and clinical markers for a specific genetic form of Parkinson's disease linked to the LRRK2 gene. Researchers will compare 10 people with LRRK2-related Parkinson's to 10 people with sporadic Parkinson's using blood tests, brain MRI scans,…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans reveal clues to ADHD and OCD in teens
Knowledge-focused Not yet recruitingThis study looks at brain activity in teenagers aged 10 to 17 with ADHD, OCD, or no diagnosis. Researchers will use EEG, MRI, and MEG to measure brain signals while participants do computer tasks. The goal is to understand how the brain controls thinking and behavior, which may h…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Childhood obesity and early puberty: a new study seeks answers
Knowledge-focused Not yet recruitingThis study follows 400 children aged 5 to 7 with obesity or normal weight until age 12. Researchers will track puberty signs, hormones, genes, diet, and chemical exposures to see what predicts early puberty. No treatments are given; the goal is to gather information.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
DNA testing could make cancer drugs safer for kids
Knowledge-focused Not yet recruitingThis study looks at how a child's genes affect the way their body processes cancer medications. By testing 130 children and young adults (up to age 26) with newly diagnosed cancer, researchers hope to find genetic differences that could help doctors choose safer and more effectiv…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
HPV knowledge showdown: digital quiz vs. escape room
Knowledge-focused Not yet recruitingThis study compares two fun, game-based ways to teach nursing students about HPV. One group plays a digital quiz game (Gimkit), while the other works together in an escape room. Researchers will measure how much students learn and remember after one month. The goal is to find bet…
Phase: NA • Sponsor: Aydin Adnan Menderes University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Your childhood may be driving your food choices: new study investigates
Knowledge-focused Not yet recruitingThis natural history study looks at how life events during childhood might affect eating behaviors and weight gain in adults. Researchers will observe 110 healthy volunteers aged 18 to 60, measuring food intake, physical activity, blood sugar, and body fat. Participants will also…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Smartwatches could save young lives in ghana by catching danger signs earlier
Knowledge-focused Not yet recruitingThis study will see if using a Garmin smartwatch to continuously track heart rate, breathing rate, and oxygen levels can help doctors spot early warning signs in hospitalized children in Ghana. About 250 children with traumatic injuries or after appendix surgery will wear the wat…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects
Knowledge-focused Not yet recruitingThis study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can your nose predict brain health? new study tests smell and choices in HIV and addiction
Knowledge-focused Not yet recruitingThis study looks at how HIV and substance use disorder (SUD) affect the sense of smell and decision-making. Researchers will test 120 adults aged 18–65, including people with HIV, SUD, both, or neither. Participants will complete smell tests and computer tasks over two visits, an…
Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Spinal fluid may hold clues to breast cancer brain spread
Knowledge-focused Not yet recruitingThis study collects spinal fluid, blood, saliva, and tumor samples from 139 adults with HER2-positive or triple-negative breast cancer that has spread to other organs but not yet to the brain. Researchers will analyze these samples for tumor DNA that might predict when the cancer…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New pain test battery could speed up drug development
Knowledge-focused Not yet recruitingThis pilot study will test a new method to see how two pain medicines, naproxen and pregabalin, work in healthy adults. Up to 25 participants will receive each medicine and a placebo in random order. They will undergo several short, controlled pain tests, like a cold water hand b…
Phase: NA • Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Massive 30-Year study aims to unlock secrets of diabetes and obesity
Knowledge-focused Not yet recruitingThis study will follow 1,000 people aged 8 to 65 who are overweight, have high blood sugar, or have metabolic issues. Researchers will collect blood, saliva, urine, and stool samples during routine clinic visits, along with questionnaires about diet, sleep, and mood. The goal is …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Gut microbes may hold key to diverticular disease
Knowledge-focused Not yet recruitingThis study investigates whether the bacteria living in the gut influence the development of diverticular disease and acute diverticulitis. Researchers will compare the gut microbiota of people with and without these conditions to identify differences and risk factors. The goal is…
Sponsor: Hospital of Navarra • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New brain zapping technique tested for safety in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new form of transcranial magnetic stimulation (TMS) called high-density theta burst stimulation (hdTBS) in 35 healthy adults aged 22 to 60. The goal is to check if hdTBS is safe and to compare its effects on the brain to standard TMS. Participants w…
Phase: PHASE1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can diet boost immunotherapy? study tests High-Fiber and fasting in melanoma
Knowledge-focused Not yet recruitingThis study looks at whether adding a high-fiber diet and short-term fasting can help melanoma patients undergoing immunotherapy. Forty participants will follow a high-fiber diet, with half also doing 72-hour fasts during each treatment cycle, while 20 others serve as a control gr…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New study to uncover why stem cell transplants harm the liver
Knowledge-focused Not yet recruitingThis study follows 500 adults and children who are getting a stem cell transplant to see how their liver is affected. Researchers will track liver function, perform biopsies and scans, and look for factors that lead to liver damage. The goal is to better understand and eventually…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Breakfast showdown: High-Fat vs. High-Carb – which worsens blood fats?
Knowledge-focused Not yet recruitingThis study looks at how eating a high-fat or high-carb breakfast changes fat levels in the blood over 8 hours. Researchers will compare results among people with conditions like diabetes, fatty liver, or kidney disease, as well as healthy volunteers. Participants will have two ov…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Super-Resolution heart scans: sharper images without extra radiation?
Knowledge-focused Not yet recruitingThis study will take standard heart CT scans from 1000 adults with structural heart disease and use a super-computer to create ultra-high-resolution images. The goal is to see if these enhanced images show more detail than the originals. No new treatments are being tested; it's a…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Blood pressure Drugs' hidden impact on lungs revealed in tiny study
Knowledge-focused Not yet recruitingThis small pilot study will test two common blood pressure medicines—nicardipine and sodium nitroprusside—in 12 patients with acute respiratory failure and high blood pressure. Researchers will use a special imaging technique called electrical impedance tomography to see how thes…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New web tool aims to help partners of heavy drinkers cope and communicate better
Knowledge-focused Not yet recruitingThis study tests a web-based program for people who are worried about their romantic partner's drinking. The program teaches skills like self-care and positive communication. Researchers will first study 50 couples to understand daily patterns, then develop the program with 15 pa…
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can a heart drug help doctors see liver cancer better?
Knowledge-focused Not yet recruitingThis study explores whether a special imaging technique called parenchymal blood volume (PBV) imaging can detect changes in blood flow within liver tumors after giving a drug called nitroglycerin. The drug is commonly used for heart conditions but may temporarily increase blood f…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Lung cancer study seeks to map patient journeys
Knowledge-focused Not yet recruitingThis study reviews medical records of 250 people with advanced or metastatic non-small cell lung cancer that has a specific change in the EGFR gene. Researchers want to learn about patients' backgrounds, the treatments they receive, and how well those treatments work. The goal is…
Sponsor: Janssen-Cilag Farmaceutica Ltda. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Refugee sleep secrets: study seeks answers
Knowledge-focused Not yet recruitingThis study looks at how stress from being a refugee—like trauma, discrimination, and adjusting to a new culture—affects sleep in Bhutanese refugees living in Ohio. Researchers will hold focus groups and interviews with 70 adults to understand their sleep problems and coping strat…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
Knowledge-focused Not yet recruitingThis study examines how a type of immune cell called gamma delta T cells adapt and function in critically ill patients, both with and without sepsis. Researchers will compare these cells in healthy people, non-septic ICU patients, and septic ICU patients. The goal is to understan…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Acupuncture points may signal hidden disease activity
Knowledge-focused Not yet recruitingThis study investigates whether acupuncture points become tender or more sensitive in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. Researchers will compare skin temperature, blood flow, and pain sensitivity at specific body points b…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could zapping the ear unlock Gut-Brain secrets in Parkinson's?
Knowledge-focused Not yet recruitingThis study investigates how stimulating the vagus nerve through the ear affects stomach function and brain activity in people with Parkinson's disease. Participants receive non-invasive electrical stimulation via a device placed on the ear, and researchers measure stomach respons…
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
Knowledge-focused Not yet recruitingThis study investigates how pomegranate dietary supplements influence gut bacteria and inflammation in people with alcohol use disorder and alcohol-related liver disease. Researchers will measure levels of beneficial gut metabolites called urolithins and inflammatory markers in b…
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New drug candidate SCB0020160 enters first human safety tests
Knowledge-focused Not yet recruitingThis phase 1 trial tests a new investigational drug, SCB0020160, for the first time in humans. Healthy adult men aged 18 to 65 receive either the drug or a placebo to evaluate safety, tolerability, and how the drug moves through the body. The study also looks at whether food affe…
Phase: PHASE1 • Sponsor: SCBIO Inc. • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Learning from loss: study seeks to improve tough talks in pediatric cancer
Knowledge-focused Not yet recruitingThis study interviews bereaved parents and oncologists to understand how they discussed uncertainty during a child's cancer treatment. The goal is to find better ways for doctors and families to communicate about what the future may hold. Participants include parents whose child …
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New study aims to tell which baby birthmarks need treatment
Knowledge-focused Not yet recruitingThis study will follow 150 infants with a type of birthmark called infantile hemangioma. Some have a less active form that barely grows, while others have the typical form. Doctors will assess each baby using standard guidelines and decide whether to recommend treatment or just w…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Zapping the brain during sleep may tweak rhythms tied to schizophrenia
Knowledge-focused Not yet recruitingThis study tests whether a non-invasive electrical brain stimulation technique called TES-TI can temporarily alter sleep spindles—brain rhythms often reduced in schizophrenia. Researchers will apply the stimulation during sleep in 20 people (half with schizophrenia spectrum disor…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Do special ed teachers face more burnout? study investigates
Knowledge-focused Not yet recruitingThis study compares work-related health issues like burnout, stress, and muscle pain between general education teachers and special education teachers. About 200 teachers will fill out questionnaires about their well-being and job satisfaction. The goal is to understand if specia…
Sponsor: Lokman Hekim University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Sleep and menopause may harm diabetic women's hearts, study warns
Knowledge-focused Not yet recruitingThis study looks at how menopause and poor sleep change heart structure and function in women aged 48-58 with type 2 diabetes. Researchers will use heart ultrasounds to measure early signs of heart strain. No treatment is given; the goal is to better understand these risks.
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Eye reflex may flag hidden risk in cesarean births
Knowledge-focused Not yet recruitingThis study explores whether measuring how a woman's pupils react to light before spinal anesthesia can predict dangerous drops in blood pressure during planned cesarean sections. Researchers will observe 200 healthy pregnant women and track their pupil responses and blood pressur…
Sponsor: Al-Azhar University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Smart sensors could track brain disease at home
Knowledge-focused Not yet recruitingThis study will test whether wearable sensors can accurately monitor movement problems in people with progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). About 60 participants will wear small sensors on their chest, ankles, and wrists while doing simple task…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
25-Year Check-In: does cartilage transplant last?
Knowledge-focused Not yet recruitingThis study looks at patients who had a cartilage cell transplant (using their own cells on a special material) for knee injuries between 1999 and 2006. Researchers will check their knee function, pain, and quality of life up to 25 years after surgery. The goal is to see how well …
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Sleep Apnea's hidden toll on memory and attention revealed
Knowledge-focused Not yet recruitingThis study looks at how obstructive sleep apnea (OSA) affects thinking skills like attention and memory, and how those changes relate to quality of life. Adults newly diagnosed with OSA will take an overnight sleep test, followed by computer tasks and questionnaires. Their result…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Large survey aims to uncover hidden pain in restless legs syndrome
Knowledge-focused Not yet recruitingThis study surveys 1,000 adults with Restless Legs Syndrome (RLS) to find out how often pain is part of their symptoms and how it affects their daily lives. Participants fill out an online questionnaire about their medical history, sleep, pain, and quality of life. The goal is to…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Dermatology study aims to cut unnecessary clinic visits with simple surveys
Knowledge-focused Not yet recruitingThis study tests whether letting patients report their symptoms online can help doctors schedule follow-up visits only when needed. About 250 adults with chronic skin conditions like eczema or psoriasis will either get standard fixed appointments or flexible scheduling based on m…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New glucose monitor aims for pinpoint accuracy in diabetes care
Knowledge-focused Not yet recruitingThis pilot study tests a new continuous glucose monitor (CGM) called SAVA in 20 adults with Type 1 Diabetes. Participants wear three SAVA sensors and one standard sensor for 15 days to check how well the SAVA measures blood sugar compared to lab tests. The study also looks at com…
Phase: NA • Sponsor: SAVA Technologies Ltd. • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Pneumonia culprit may be rarer than doctors think
Knowledge-focused Not yet recruitingThis study looks at 200 people with pneumonia to find out how many actually have an infection caused by Chlamydia pneumoniae, a type of bacteria. Researchers will use PCR tests to check for the germ and compare results with standard care. The goal is to see if this infection is o…
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Phone cards boost screening confidence for pregnant patients
Knowledge-focused Not yet recruitingThis study tests a simple tool—short information cards on a mobile phone—to help pregnant people feel more confident when deciding about prenatal genetic screening. About 1,400 participants will use the cards before their first doctor visit, or receive usual care. Researchers wil…
Phase: NA • Sponsor: Case Western Reserve University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Swallowing science: new study aims to standardize how we measure dysphagia
Knowledge-focused Not yet recruitingThis study will compare two different devices that measure pressure and flow during swallowing in 25 healthy adults. The goal is to see how differences in the devices affect the measurements, which could help standardize the diagnosis of swallowing disorders (dysphagia). Particip…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Heart-Kidney link under microscope in advanced heart failure study
Knowledge-focused Not yet recruitingThis study follows 100 adults with advanced heart failure for 2 years to understand how kidney function changes over time and how it relates to serious heart events like death or need for a transplant. Researchers will collect blood, urine, and stool samples, along with quality-o…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Heart Pump's impact on failing hearts to be measured in new study
Knowledge-focused Not yet recruitingThis study will observe how the Impella 5.5 heart pump changes the way the heart squeezes and works in adults with end-stage heart failure. Researchers will use ultrasound (echocardiography) to measure heart function before, right after, and 7-14 days after the pump is placed. Th…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Kidney filter study tests safer dialysis for acute kidney failure
Knowledge-focused Not yet recruitingThis study looks at how well a specific kidney filter (multiFlux 160) works when used with two different blood thinners—heparin or citrate—during continuous kidney replacement therapy. The goal is to see which approach keeps the filter working effectively while avoiding side effe…
Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Flat feet fix may shift kneecap alignment, small study hints
Knowledge-focused Not yet recruitingThis study tests whether correcting a flat foot position with shoe inserts (orthoses) changes how the kneecap sits during standing. Ten adults with flexible flatfoot will have weight-bearing CT scans with and without orthoses, with knees straight and slightly bent. The goal is to…
Phase: NA • Sponsor: Regionshospital Nordjylland • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Gut-Brain link after severe head injury: a new clue to preventing further damage
Knowledge-focused Not yet recruitingThis study investigates why severe traumatic brain injury (sTBI) often leads to additional brain damage. Researchers think changes in the gut and immune system may play a key role. They will analyze blood, stool, and other samples from 40 adults with sTBI, as well as from trauma …
Sponsor: Corewell Health West • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Hidden toll of myasthenia gravis: study probes sexual and bladder problems often overlooked
Knowledge-focused Not yet recruitingThis study investigates sexual and urinary problems in people with generalized myasthenia gravis, an autoimmune disease that causes muscle weakness. While visible symptoms like droopy eyelids are well-known, issues like sexual dysfunction and bladder problems are often ignored. R…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could poor balance be the hidden link between MS fatigue and fear of falling?
Knowledge-focused Not yet recruitingThis study investigates whether balance problems explain why fatigue leads to a greater fear of falling in people with multiple sclerosis (MS). Researchers will assess fatigue, balance, and fear of falling in 40 adults with MS who can walk independently or with a device. The goal…
Sponsor: Uskudar University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could knowing the risks mean needing less medicine?
Knowledge-focused Not yet recruitingThis study looks at whether people who better understand the risks and steps of their upcoming lung procedure (endobronchial ultrasound) need less propofol, a sedative. Researchers will ask participants questions about what they understood from the consent process and measure the…
Sponsor: Uludag University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Nose reconstruction or prosthesis? study aims to settle the debate
Knowledge-focused Not yet recruitingThis study compares two ways to rebuild the nose after partial or total loss: surgery using skin flaps, or a custom-made prosthetic nose (epithesis). Researchers will ask people who had either treatment at least one year ago to fill out a questionnaire about how their nose looks …
Sponsor: Hôpital NOVO • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could Breast-Conserving surgery be safe for women with multiple tumors?
Knowledge-focused Not yet recruitingThis study looks at whether breast-conserving surgery (removing only the tumor, not the whole breast) is safe for women diagnosed with multifocal or multicentric breast cancer—meaning they have two or more tumors in one breast. Researchers will follow 100 adult women for at least…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Weight loss drugs may turn back the biological clock, study hints
Knowledge-focused Not yet recruitingThis study will follow 440 adults aged 40-89 who are starting a weight management program that includes drugs like semaglutide or tirzepatide along with lifestyle coaching. Researchers will measure changes in biological age using a blood-based aging clock over 6 months. The goal …
Sponsor: National University of Singapore • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New program aims to smooth healthcare transition for teens with rare hormone disorder
Knowledge-focused Not yet recruitingThis study tests a structured program to help 40 adolescents and young adults with congenital adrenal hyperplasia (CAH) move from pediatric to adult healthcare. Participants will learn about their condition, emergency preparedness, and self-management. The goal is to see if the p…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can targeted sedation help patients breathe easier on oxygen therapy?
Knowledge-focused Not yet recruitingThis study looks at how two sedative drugs, dexmedetomidine and remifentanil, affect breathing effort in patients with acute hypoxemic respiratory failure who are receiving high-flow nasal oxygen. Researchers will measure changes in inspiratory effort and symptoms like shortness …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Spine fracture study to reveal hidden degeneration risks
Knowledge-focused Not yet recruitingThis observational study will follow 150 people with thoracolumbar spine fractures to see how the injury and its treatment (surgery or non-surgical care) affect joint and disc degeneration over time. Researchers will compare CT scans and pain scores between treated patients and a…
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Blood test could revolutionize rectal cancer monitoring
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that finds tiny bits of tumor DNA (ctDNA) can help doctors monitor rectal cancer more closely than standard scans. Researchers will collect blood and tissue samples from 60 adults with non-spreading rectal cancer before and after standard …
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Non-Invasive test may predict liver transplant failure in real time
Knowledge-focused Not yet recruitingThis study explores whether a non-invasive test called the vascular occlusion test (VOT), used with near-infrared spectroscopy, can predict early allograft dysfunction (EAD) in adults receiving a liver transplant. EAD is a serious complication that can lead to organ failure. Rese…
Sponsor: Ippokrateio General Hospital of Thessaloniki • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Scientists track everyday exposures to unlock secrets of healthy aging
Knowledge-focused Not yet recruitingThis study investigates how a person's total environment—including lifestyle habits like diet and exercise, social factors, and exposure to pollutants—affects the aging process. Researchers will follow 400 volunteers aged 55 and older from southeastern France, collecting blood sa…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Study seeks clues to predict who needs closer colon checks after polyp removal
Knowledge-focused Not yet recruitingThis study looks at people who have had certain types of colon polyps (serrated lesions) removed. It aims to find out why some of them later develop new advanced growths in the colon. By tracking 750 adults over time, researchers hope to identify risk factors that could help doct…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
AI Co-Pilot for rural doctors: could a language model improve care for diabetes and hypertension?
Knowledge-focused Not yet recruitingThis study tests whether a large language model (LLM) — a type of AI — can help village doctors make better care plans for patients with type 2 diabetes and high blood pressure. About 20 rural doctors will review standardized patient cases, with half receiving AI-assisted decisio…
Phase: NA • Sponsor: Jiangsu Taizhou People's Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could shedding pounds boost your job performance? study investigates weight, lifestyle, and work
Knowledge-focused Not yet recruitingThis observational study looks at how being overweight or obese, and changes in lifestyle, impact work performance, quality of life, and well-being in medical residents. Researchers will track 600 participants for 12 months, measuring body weight, lifestyle habits, and using ques…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Scientists pinpoint optimal sedation dose for safer gastroscopy across ages
Knowledge-focused Not yet recruitingThis study aims to find the 90% effective dose of tegileridine, a painkiller, when combined with propofol for sedation during painless gastroscopy. Researchers will test different doses in young (18-65) and elderly (65+) adults to see which dose best prevents movement, coughing, …
Phase: PHASE4 • Sponsor: Shiyou Wei • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality fights pharmacy stigma for sickle cell patients
Knowledge-focused Not yet recruitingThis study tests whether a computer simulation can help pharmacists and pharmacy students better understand the pain struggles of sickle cell disease patients. About 200 healthcare professionals will use a point-of-view simulation and then complete surveys to see if their misconc…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
AI could slash MRI scan times without sacrificing quality
Knowledge-focused Not yet recruitingThis study explores whether artificial intelligence can help perform high-field whole-body MRI scans faster while keeping image quality high. Researchers will compare standard MRI sequences with AI-accelerated versions in 600 adults undergoing screening for prostate, lung, or vas…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Scottish data to reveal if RSV shot shields newborns
Knowledge-focused Not yet recruitingThis study looks at health records of babies born in Scotland to see if those whose mothers received the RSV vaccine (ABRYSVO) during pregnancy have fewer hospital visits for RSV. No new participants are enrolled; researchers will analyze existing data. The goal is to understand …
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Womb waves: could uterine contractions predict IVF success?
Knowledge-focused Not yet recruitingThis study looks at whether the natural contractions of the uterus (called endometrial peristalsis) influence the chance of pregnancy in women undergoing frozen embryo transfer with hormone replacement therapy. Researchers will measure these contractions using ultrasound at three…
Sponsor: Mỹ Đức Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can a 2-week drug boost scan accuracy for hidden prostate cancer?
Knowledge-focused Not yet recruitingThis study looks at whether taking bicalutamide for two weeks can make PSMA PET/CT scans better at finding small amounts of prostate cancer that standard scans might miss. It involves 20 men with recurrent prostate cancer and very low PSA levels. Participants are randomly assigne…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Timing of gum disease check-ups could change treatment success
Knowledge-focused Not yet recruitingThis study looks at whether checking gum health 4 weeks after non-surgical treatment is better than waiting 8-10 weeks. Researchers will compare healing and pocket depth in 24 adults with advanced gum disease. The goal is to find the best time for follow-up to improve care.
Phase: NA • Sponsor: Gulf Medical University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Personalized brain training may boost cochlear implant performance
Knowledge-focused Not yet recruitingThis study investigates whether auditory and cognitive training can help adults with cochlear implants understand speech better. Researchers will enroll 100 experienced implant users and randomly assign them to different training programs. The goal is to see if these intervention…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Massive european TB registry aims to map the disease and sharpen treatment
Knowledge-focused Not yet recruitingThis study collects long-term data from tuberculosis patients across Europe to better understand the disease and its treatment. Researchers track risk factors, diagnostic details, side effects, and outcomes for both drug-sensitive and drug-resistant TB. The goal is to identify wh…
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Chewing gum test reveals hidden impact of gum disease
Knowledge-focused Not yet recruitingThis study will measure how well people with gum disease can chew. One hundred adults with periodontitis will chew a special gum for 20 cycles to test their chewing performance. Researchers will also check the severity of their gum disease to see if there is a link. This is an ob…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Which stone removal method works best for special bladder pouches?
Knowledge-focused Not yet recruitingThis study compares four surgical techniques for removing bladder stones in patients who have a continent catheterizable urinary reservoir, a surgically created pouch that stores urine. The techniques include using a mini-percussion device through the stoma, a flexible scope thro…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New study tracks hidden dangers of common leukemia drug
Knowledge-focused Not yet recruitingThis study will follow 200 children with acute lymphoblastic leukemia or lymphoma to learn more about the short- and long-term side effects of asparaginase drugs. Researchers will track how often serious toxicities occur during standard treatment and a newer therapy called SJALL2…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could a leukemia drug stop deadly brain tumor spread?
Knowledge-focused Not yet recruitingThis early study tests whether asciminib, a drug already approved for leukemia, can get into brain tumors in children and young adults (ages 6-25) with recurrent brain tumors. Some participants will also get sildenafil to see if it helps the drug enter the tumor. The main goal is…
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can knowledge boost your relationship? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether learning about well-being can improve how romantic partners think and feel. About 2,000 couples with mild depression symptoms will take online surveys about their emotions and relationship satisfaction. The goal is to see if gaining knowledge about wel…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
4D MRI scans could reveal hidden clues about heart disease and cancer
Knowledge-focused Not yet recruitingThis study uses advanced 4D MRI scans to measure blood flow and heart function in adults with heart disease or cancer. Researchers aim to see if these detailed images can help predict how these diseases will progress. The study involves 1,000 participants who are already schedule…
Sponsor: Ulsan University Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple blood test predict lupus in children with ITP?
Knowledge-focused Not yet recruitingThis study looks at children with immune thrombocytopenic purpura (ITP) who also have certain antibodies, as they are at higher risk of developing lupus. Researchers will analyze blood samples to track immune cell changes and markers that may signal the transition to lupus. The g…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tiny study asks: can spine specialists see the same thing on CT?
Knowledge-focused Not yet recruitingThis study checks how consistently six doctors can grade degeneration of the small joints in the spine (facet joints) using CT scans. It includes 12 patients and uses the Pathria scale. The goal is to see if the grading method is reliable, not to test a treatment.
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Experimental device tested in humans – no approval yet
Knowledge-focused Not yet recruitingThis trial is testing a medical device that has not been approved by the U.S. FDA. The purpose is to gather information about how the device works and its safety in people. Participants will be monitored closely, but the device is not yet proven to treat or cure any condition.
Phase: NA • Sponsor: AtaCor Medical, Inc. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a quick ultrasound keep heart failure patients out of the hospital?
Knowledge-focused Not yet recruitingThis study will test whether a five-point ultrasound can better predict fluid overload in 200 patients hospitalized with congestive heart failure. Doctors will use the ultrasound results to guide diuretic treatment and track readmission rates over 30 and 90 days. The goal is to s…
Phase: NA • Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Massive data dive aims to uncover best prostate cancer treatments in real life
Knowledge-focused Not yet recruitingThis study looks at how men with advanced prostate cancer that no longer responds to hormone therapy are treated in real-world clinics across the United States. Researchers will analyze data from over 17,000 patients to see which therapies are used, in what order, and how long th…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Kazakh Women's body secrets revealed: diet, sleep, and scans uncover health clues
Knowledge-focused Not yet recruitingThis study looks at how diet, physical activity, and sleep relate to body composition in women in Kazakhstan. About 200 women aged 20 and older will have a DEXA scan to measure fat, muscle, and bone density, and fill out questionnaires. The goal is to build a clearer picture of w…
Sponsor: Nazarbayev University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Mass screening aims to catch silent killers early in pakistan
Knowledge-focused Not yet recruitingThis study screens adults aged 18 and older in suburban and peri-urban areas of Faisalabad, Pakistan, for four major noncommunicable diseases: diabetes, hypertension, obesity, and high cholesterol. Participants who are found to have these conditions are referred to doctors for st…
Sponsor: Getz Pharma • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New turkish questionnaire aims to measure how teens see their scoliosis
Knowledge-focused Not yet recruitingThis study translates and tests a Turkish version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS), a tool designed to measure body image and perceived deformity in teens with scoliosis. Researchers will enroll 100 adolescents aged 10–19 with idiopat…
Sponsor: Acibadem University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists probe sonic hedgehog pathway for clues to brain AVM treatment
Knowledge-focused Not yet recruitingThis study investigates the role of the Sonic Hedgehog signaling pathway in brain arteriovenous malformations (AVMs), abnormal tangles of blood vessels that can cause bleeding or stroke. Researchers will analyze leftover brain tissue from 20–30 adults undergoing AVM surgery and c…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
3,000 volunteers to reveal hidden heart risks in qatar
Knowledge-focused Not yet recruitingThis study follows 3,000 adults in Qatar—both citizens and long-term residents—to track how cardiometabolic conditions like diabetes and heart disease develop over time. Participants are grouped by blood sugar status (normal, pre-diabetes, or diabetes) and monitored for major car…
Sponsor: Weill Cornell Medical College in Qatar • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can regular exercise sharpen your mind and improve sleep?
Knowledge-focused Not yet recruitingThis study looks at whether university students who exercise regularly have better cognitive awareness, body awareness, and sleep quality compared to those who are sedentary. Researchers will survey 140 students aged 18-25, grouping them by their physical activity levels. No drug…
Sponsor: Yeditepe University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Genetic clue may unlock why lupus hits some people harder
Knowledge-focused Not yet recruitingThis study investigates whether a specific gene variation (ICOS) is linked to developing systemic lupus erythematosus (SLE) and how severe the disease becomes. Researchers will analyze blood samples from 30 people diagnosed with SLE to look for patterns in the ICOS gene. The goal…
Sponsor: South Valley University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Mapping the next steps: how men with advanced prostate cancer are treated after standard therapies fail
Knowledge-focused Not yet recruitingThis study looks at real-world data from over 1,000 men with metastatic castration-resistant prostate cancer (mCRPC) who have already received several standard treatments, including hormone therapy, chemotherapy, and a targeted radiation drug called Lu-177 PSMA-617. Researchers w…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Liver transplant Patients' sleep under the microscope
Knowledge-focused Not yet recruitingThis study follows adults waiting for a liver transplant to see how their sleep quality changes from before surgery to six months after. Researchers use questionnaires to measure sleep, anxiety, and other factors. The goal is to understand what influences sleep problems in these …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Liver health may change how a promising cancer drug works in the body
Knowledge-focused Not yet recruitingThis study investigates how the experimental cancer drug atirmociclib is processed by the body in people with mild, moderate, or severe liver disease compared to those with healthy livers. Participants receive a single oral dose of the drug, and blood samples are taken over time …
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Superbug sleuths decode the DNA of drug-resistant e. coli to stop its spread
Knowledge-focused Not yet recruitingThis study examines the genetic makeup of carbapenem-resistant E. coli bacteria collected from patients in southern France. Researchers will sequence the bacteria's full genomes to identify different strains, resistance genes, and virulence factors. The goal is to understand how …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New study uses DNA to track hidden gonorrhea in partners
Knowledge-focused Not yet recruitingThis study will recruit 100 sexual partners of people diagnosed with gonorrhea. Researchers will take an extra throat swab to analyze all the bacteria and their genes using a technique called metagenomics. The goal is to find hidden infections, antibiotic resistance, and see how …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New doppler study aims to spot fetal distress earlier in Growth-Restricted pregnancies
Knowledge-focused Not yet recruitingThis study looks at blood flow in a part of the fetal heart called the aortic isthmus in pregnancies where the baby is not growing well (fetal growth restriction). Researchers will compare Doppler measurements between affected fetuses and healthy ones to see if these patterns can…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple heart catheter test predict serious complications after myocarditis?
Knowledge-focused Not yet recruitingThis study investigates whether measuring blood flow in the heart's smallest blood vessels (microcirculation) can help predict serious health events within a year after a person is hospitalized for acute myocarditis. Researchers will use a special technique during a standard hear…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a cartoon video save lives? new trial tests breast cancer education in palestine
Knowledge-focused Not yet recruitingThis study tests whether an animated video or a training booklet can improve breast cancer and screening knowledge among Palestinian women aged 40-69. Participants are randomly assigned to receive one of the two educational tools. The goal is to see which method better boosts und…
Phase: NA • Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Kidney transplant experiment halted before it began
Knowledge-focused Not yet recruitingThis study planned to test whether kidneys with small, low-risk tumors could be removed from donors, have the tumor taken out, and then be transplanted into patients with kidney failure. The goal was to increase the number of available donor kidneys. However, the study was withdr…
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC